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ABSTRACT 
 
Chromium-Catalyzed Homoaldol Equivalent Reaction, Indium-Mediated 
Cycloisomerization, and Palladium-Catalyzed Cross-Coupling Reaction. (August 2011) 
Jun Yong Kang, B.S., Konyang University, Korea; M.S., San Francisco State University; 
M.S., Texas A&M University 
Chair of Advisory Committee: Dr. Brian T. Connell 
 
 The homoaldol reaction is one of the most powerful methods for the construction 
of C–C bonds as well as 1,4-oxygenated compounds yet this reaction remains a 
challenging task due to the instability of homoenolates which spontaneously cyclize to 
the cyclopropanolate. A regioselective catalytic homoaldol equivalent reaction of 3-
bromo vinyl acetate with aldehydes under Cr(III)-Mn(0) redox condition is developed. 
This homoaldol equivalent reaction allows access to the 1,4-oxygenated compounds that 
are not possible by a conventional aldol process. Mild hydrolysis of the vinyl acetate and 
reduction of the homoaldol adducts generate diols and lactols in high yield (99%). 
Further manipulation including stereoselective epoxidation and cyclopropanation is 
achieved in an efficient manner. 
Furans, found in many natural products and utilized in drug discovery, have been 
well studied but current synthetic methods toward furans have some limitations in 
functional group tolerance, substrate scope, and low product yield in many cases. A 
highly efficient and catalytic cycloisomerization reaction that transforms acetylenic α,β-
  
iv 
epoxides to 2,3,5-tri-substituted furans under InCl3 catalysis is developed. This reaction 
sequence allows access to rapid construction of highly valuable, tri-substituted furan 
derivatives.  
Cross-coupling reactions utilizing transition metals and Lewis acids are 
important synthetic tools for the formation of C–C and C–N bonds and a number of 
cross-coupling reactions between α-bromo carbonyl compounds and metal reagents such 
as aryl metals, alkenyl metals, and alkyl metals are reported. Transition metal-catalyzed 
cross-coupling reaction for the construction of α-alkynyl carbonyl compounds is 
reported in a limited case. The first approach to secondary α-alkynyl carbonyl 
compounds from secondary α-bromo esters and amides with 
tributyl(phenylethynyl)stannane under palladium-catalyzed cross-coupling reaction 
conditions is developed. This synthetic method allows access to secondary α-alkynyl 
carbonyl compounds which are valuable precursors in pharmaceuticals and agricultural 
applications. 
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CHAPTER I 
INTRODUCTION: CHROMIUM-CATALYZED HOMOALDOL EQUIVALENT 
REACTIONS  
1.1 Introduction and Background of Homoaldol Equivalent Reactions 
The power of homoaldol reactions1,2 in synthetic methodology have been 
demonstrated by their own convenient access to useful building blocks containing 1,4 
oxygenated subunits that are often found in natural products.3 These products are not 
accessible by conventional aldol process4 and can be applied to development of versatile 
and valuable transformations such as stereoselective epoxidation,5 stereoselective 
cyclopropanation,6 lactol formation, and 1,4-diol synthesis. While aldol reactions have 
been extensively studied for making carbon-carbon bonds over the past decades,7 one 
carbon homologated aldol reaction, referred to as the homoaldol reaction, has been less 
studied due to the stability of homoenolate7 that posses both nucleophilic and 
electrophilic sites and undergoes rapid cyclization to the oxy anionic isomers (Scheme 
1.1). Although the early observation of homoenolate anion date back in 1962,8 the 
homoenolate remains as a synthon with no examples in literature.  
 
Scheme 1.1. Homoenolate possessing both nucleophilic and electrophilic sites  
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Since Nickon’s discovery of homoenolate equivalent reagents, there have been 
many strategies for accessing homoenolate equivalents. In early work employing 
homoaldol equivalent reactions, stoichiometric amounts of catalyst were used in 
homoaldol equivalent reactions. Büechi and Wuest in 19699 utilized Grignard reagents 2 
of homoenolate equivalents and carbonyl compounds 1 to afford the acetal protected 
tertiary alcohol 3 which could proceed to homoaldol equivalent adducts after hydrolysis 
of acetal protecting group (Scheme 1.2). However, this method employing the Grignard 
reagent has the potential for cyclopropyl ether formation by a 1,3-cycloelimination of the 
Grignard reagent 2.       
In 1977, Nakamura and Kuwajima reported the first example of an ester 
homoenolate equivalent generated from silyloxy cyclopropane and titanium tetrachloride 
(TiCl4) for homoaldol equivalent reactions.10 The silyloxy cyclopropane 4 was treated 
with TiCl4 to generate titanium homoenolate ester 5 which consequently was reacted 
with aldehyde 6, producing the γ-hydroxy ester 7 of homoaldol equivalent adduct 
(Scheme 1.2). One year later, Sakurai et al. employed α-siloxy allylsilane for 
homoenolate equivalent formation and acid chloride to afford γ-keto aldehydes of  the 
desired homoaldol equivalent adduct (Scheme 1.2).11 Treatment of α-siloxy allylsilane 8 
with acid chloride 9 under TiCl4 (1.1 equiv) produced the γ-keto aldehydes 10. These 
reactions, however, employed stoichiometric amount of TiCl4 to induce homoenolate 
equivalent reagents. Instability of the anions, formation of the Brook rearrangement 
byproducts, and lack of regioselectivity are all potential problems of α-siloxy allylsilane 
8. 
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Scheme 1.2. Stoichiometric Homoaldol Equivalent Reaction  
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 Utilization of Grignard reagent 2 and TiCl4 for generation of homoenolate 
equivalent reagents from silyloxy cyclopropane 4 and α-siloxy allylsilane 8 revealed 
several issues, including both decomposition of Grignard reagents and stoichiometric 
use of titanium reagents. Recognizing these problems, Hoppe approached these issues 
by enantioselective deprotonation of alkenylcarbamate.12  
 Hoppe’s research toward homoaldol equivalent formation focused on α-
deprotonation of 2-alkenylcarbamate 11 with n-BuLi to generate lithiated 
alkenylcarbamate 12, which subsequently underwent lithium-titanium exchange 
addition of the carbonyl compound to construct the homoaldol equivalent adduct 13 
(Scheme 1.3). This procedure presents a successful deprotonation of the 
alkenylcarbamate 11 with retention of stereochemistry and affords the stereoselective 
homoaldol equivalent adducts. Nonetheless, this method suffers from low yields with 
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poor enantioselectivity and requires chiral carbamate substrates. The racemization of the 
lithium complex 12 is one plausible reason for low enatioselectivity in this reaction.  
 
Scheme 1.3. Enantioselective Homoaldol Equivalent Reaction 
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 Employing chiral diamine (–)-sparteine and s-BuLi for stereoselective lithiation 
of prochiral butenyl carbamates 14,13 Hoppe and Zchage improved both selectivity and 
product yields of the asymmetric homoaldol equivalent reaction. Crystallization of 
diamine complexes produced only the desired diamine complex 15. This complex 
underwent transmetallation with Ti(Oi-Pr)4 generating a stable titanium complex which 
was then treated with aldehyde to afford the anti homoaldol adduct 16 (Scheme 1.3). 
However, this homoaldol equivalent reaction has limited substrate scope and still 
requires stoichiometric amount of titanium reagents.  
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 The catalytic homoaldol equivalent reaction describing formation of γ-hydroxy 
esters 18 from silyloxy cyclopropane 4 and benzaldehyde 17a under titanium catalyst 19 
was reported by Gleason in 1999 (eq 1).14 A proposed catalytic cycle of titanium-
catalyzed transformation of silyloxy cyclopropane 4 and benzaldehyde 17a to γ-hydroxy 
esters 18 is described in Scheme 1.4. Ring opening of silyloxy cyclopropane 4 under 
titanium catalyst 19 generates the alkoxy thitanium homoenolate 20. The homoenolate 
equivalent 20 undergoes addition to aldehyde 17a, activated by a co-catalyst of 
trimethylsilyl triflate 21 forming intermediate 22 and affording the homoaldol 
equivalent adducts 18 in the catalytic cycle (Scheme 1.4). 
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Scheme 1.4. Proposed Catalytic Cycle of Titanium-Catalyzed Transformation 
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Since Gleason reported the first catalytic generation of homoenolate equivalents, 
a number of different approaches to homoaldol equivalent reactions employing various 
catalytically generated homoenolates have been reported. For instance, Lombardo and 
co-workers in 2002 introduced chromium-catalyzed homoaldol equivalent reactions 
utilizing 3-chloro-propenyl ester 23 and carbonyl compound 17i under chromium 
catalyst (CrCl3) to afford homoaldol equivalent adducts 24 (Scheme 1.5).15 Chromium 
(II) oxidatively added to 3-chloro-propenyl ester 23, in which allylchromium (III) 
complex was generated. The allylic chromium complex was added to carbonyl 
compound 17i to produce homoaldol equivalent adducts 24 and 1,2-diol moieties 25. 
Formation of 1,2-diol moieties 25 caused low yield of the desired homoaldol equivalent 
product 24. Regioselectivity of this reaction was influenced by solvents. Replacement of 
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DMF by acetonitrile increased reaction rate but regioselectivity was reversed in favor of 
diol derivatives. In addition, this reaction requires the use of a catalytic amount of 
tetrabutylammonium iodide (TBAI) to generate 3-iodo-propenyl esters in situ. This 
reaction has demonstrated oxidative addition of Cr(II) to allylic halides under Nozaki-
Hiyama-Kishi type reaction conditions but yield and regioselectivity remains low.  
Recently, Christian and Glorius in 2004 disclosed a catalytic generation of 
homoenolate equivalents and further reported their application to homoaldol equivalent 
reactions. N-Heterocyclic carbenes 27, which can catalyze formation of homoenolate 
equivalents, is a new strategy for generating homoenolate for use with homoaldol 
equivalent reaction.16 This reaction protocol has allowed use of organocatalyzed, 
stereoselective homoaldol equivalent reactions of α,β-unsaturated aldehydes 17f with 
aromatic aldehyes 26 to afford γ-butyrolactones 28 (Scheme 1.5). However, the reaction, 
generating homoenolate equivalents via previously unprecedented procedure, exhibits 
low product yield and stereoselectivity. In spite of the fact that very significant 
contributions to the homoaldol equivalent reaction have been made, efficient, mild, and 
catalytic methods for generation of homoenolates for use in homoaldol equivalent 
reaction need to be developed.  
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Scheme 1.5. Catalytic Homoaldol Equivalent Reaction 
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1.2 Specific Aim 
The purpose of this project is to develop a synthetic method for regioselective, 
catalytic homoaldol equivalent reactions that can generate hydroxy vinyl acetates of 
homoaldol equivalent adducts suitable for further various manipulation to hydroxyl-
directed epoxidations, hydroxyl-directed cyclopropanations, and hydrolysis to generate 
the homoaldol equivalent adducts (Scheme 1.6). This chapter describes the development 
of synthetic methods for generating homoaldol equivalent products and further 
manipulation of these homoaldol adducts to make valuable building blocks in organic 
synthesis. 
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Scheme 1.6 Proposed Generation of Homoaldol Adducts and Manipulation  
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1.3 Cr-Catalyzed Homoaldol Equivalent Reaction 
 Chromium-mediated additions of allylic nucleophiles to electrophiles such as 
aldehydes, in the Takai–Utimoto17 and Nozaki–Hiyama–Kishi18 reactions (Scheme 1.7), 
as well as the catalytic variant reported by Fürstner,19 are well-developed processes. We 
have developed a mild, efficient, catalytic method for generation of homoenolate 
equivalents mediated by a chromium catalyst and applied this method to highly 
regioselective intermolecular homoaldol equivalent reactions (Table 1.1). 
 
Scheme 1.7. Chromium-Mediated Coupling Reactions 
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Table 1.1. Initial Screening Results of Homoaldol Equivalent Reactiona 
1
3
4
5
6
7
8
10
11
entry solvent yield (%)b
Br OAc
catalyst(10-30 mol%)
 additive, Mn(2 equiv) 
 solvent, rt
then TBAF
Ph
OH
OAc
+
O
Ph
OPiv
OPiv
OAc
OAc
29a
29b
29c (E/Z=2:1)
nucleophile additive
29a
29a
29a
29a
29a
29a
29b
29b
29c
THF
THF
MeCN
MeCN
MeCN
MeCN
THF
MeCN
THF
THF
DIPEA, TMSCl
DIPEA, TMSCl
DIPEA, TMSCl
DIPEA, TMSCl
DIPEA, TMSCl
TEA, TMSCl
0
0
0
0
0
30
0
30
45c
99c
catalyst
CrCl2
CrCl3
CrCl3
CoBr2
CoBr2
CrCl3
CoBr2
CrCl3
CrCl3
CrCl3
17a 30a
H
TMSCl
12
13
14
29c
29c
29c
THF
THF
THF
TMEDA, TMSCl 44c
71c
90c
CrCl3
CrCl3
CrCl3 DIPEA, TMSCl
(H2NCH2)2, TMSCl
15 29c MeCN 50cCrCl3 TEA, TMSCl
2 29a THF TEA, TMSCl 0CrCl3
9 29b MeCN DIPEA, TMSCl 0CoBr2
16 29c
 
a Reactions were performed using nucleophiles (29a, 29b, or 29c (0.64 mmol)), 
aldehydes 17a (0.32 mmol),    catalysts (CrCl3 (0.032 mmol), CrCl2 (0.032 
mmol), CoBr2 (0.096 mmol)), Mn0 (0.64 mmol), base (TEA (0.048 mmol), 
DIPEA (0.048 mmol)) and TMSCl (0,64 mmol) in THF (2 mL) or MeCN (2 
mL)  at rt for 20 h and quenched with saturated aqueous NaHCO3 solution. b 
Isolated yield. c yield after deprotection of TMS protecting group with TBAF. 
 
 As Lombardo’s early studies had revealed that acetoxyallyl chlorides are not 
efficient nucleophiles in chromium-catalyzed additions to aldehydes,15 we employed 
masked carbonyls 29a and 29b, and the presumably more reactive allyl bromide 29c (3-
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bromopropenyl acetate) as nucleophiles for addition to benzaldehyde 17a (Table 1.1). 
We began these studies with chromium-mediated addition of homoenolate equivalent to 
aldehydes to introduce homoaldol equivalent products. Our preliminary results in this 
study led us investigate the chromium catalyst CrCl3 with 3-bromo vinyl acetate 29c for 
this homoladol equivalent reaction. Nucleophiles 29a and 29b did not proceed in the 
homoladol equivalent product with CrCl3 and additives of bases and trimethylsilyl 
chloride (TMSCl) (Table 1.1, entries 2 and 8) yet led to 30% yield with CoBr2 without 
additives (Table 1.1, entries 7 and 10). Addition of additives of bases and TMSCl in the 
reaction with nucleophiles 29a and 29b under CoBr2 did not afford the homoladol 
equivalent products (Table 1.1, entries 6 and 9). It was observed that nucleophiles 29a 
and 29b under CoBr2 proceed in homoaldol equivalent products without additives in 
polar solvent such as acetonitrile (Table 1.1, entries 7 and 10). On the other hand, 
nucleophile 29c provided 99% yield under the reaction conditions (Table 1.1, entry 
16).20  
Interestingly, we observed significant acceleration of reaction rate with 
triethylamine (TEA) as an additive (Table 1.1, entry 16). In order to optimize choice of 
base, we explored different bases raging from bidentate bases to monodentate bases in 
the homoaldol equivalent reactions. Bidentate bases such as tetramethylethylenediamine 
(TMEDA) and ethylenediamine provided the homoaldol equivalent adducts in 44% and 
71% respectively (Table 1.1, entries 12 and 13). Monodentate bases including 
diisopropylethylamine (DIPEA) and triethylamine (TEA), however, afforded the 
homoaldol equivalent products in 90% and 99% respectively (Table 1.1, entries 14 and 
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16). This result revealed that sterics are crucial factors for successful homoaldol 
equivalent reactions requiring sterically less demanding bases.   
Experiments to probe the influence of this additive were undertaken in two 
different reaction flasks, one with TEA and the other one without TEA. The rate of 
reactions without the TEA additive is very slow and the reaction without TEA does not 
go to completion under the standard reaction condition (20 h). Other bases such as 
chelating diamines were less effective. 
With these optimized catalytic reaction conditions in hand, various aldehydes 
with 3-bromo vinyl acetate 29c were screened under the standard reaction conditions 
shown in Table 1.2. Aromatic aldehydes 17a, 17b, 17c (Table 1.2) afford higher yield 
than aliphatic aldehydes 17g, 17h (Table 1.2) yet the unsubstituted parent aromatic 
aldehyde 17a provided the highest yield (99%).20 It was observed that steric effects were 
more crucial than electronic effects regarding the product yield. Ortho-substituted 
aldehydes, including 2-methylbenzaldehyde 17d and 2-bromobenzaldehyde 17e, 
generate lower product yield than para-substituted aldehydes such as 4-
methoxybenzaldehyde 17b and 4-trifluorobenzaldehyde 17c (Table 1.2). Evidence of 
this idea is supported by the fact that employment of 2,6-dimethylbenzaldehyde as an 
electrophile leads to very slow conversion and low yield (<50%). It is noteworthy that 
para-nitrobenzaldehyde generates low product yield (<50%) probably due to lack of 
solubility. 
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Table 1.2. Scope of Homoaldol Equivalent Reactiona 
OH
OAc
Br
OAc
 CrCl3 (10 mol%), Et3N (15 mol%) 
TMSCl/Mn0 (2 equiv )
R
OH
OAc
+
O
R
29c (E/Z=2:1)17 Z-30
H
THF, 20 h, then TBAF
OH
OAc
MeO
OH
OAc
F3C
OH
OAc
CH3
OH
OAc
Br
OH
OAc
OH
OAc
OH
OAc
OH
OAc
OH
OAcMe
O OH
OAcMeO
O
OH
OAc
N
OH
OAc
TBDMSO
OH
O
O
OAc
30a, 99%
30b, 90%
30c, 91%
30d, 82%
30e, 78%
30f, 85%
30g, 75%
30h, 80%
30i, 96%
30j, 70%
30k, 71%
30l, 75%
30m, 99%c
30n, 96%
SM productb
O
H
H
O
MeO
H
O
F3C
H
O
CH3
H
O
Br
H
O
H
O
H
O
SM productb
H
O
H
O
Me
O
H
O
MeO
O
H
O
N
H
O
TBDMSO
O
O
O
H
17a
17b
17c
17d
17e
17f
17g
17h
17i
17j
17k
17l
17m
17n
 
a Reactions were performed using 29c (0.64 mmol), aldehydes 17 (0.32 mmol), CrCl3 (0.032 mmol), Mn0 
(0.64 mmol), Et3N (0.048 mmol), and TMSCl (0.64 mmol) in 2 mL THF at rt for 20 h, quenched with 
saturated aqueous NaHCO3 solution, and deprotected with TBAF. b Isolated yield. c 24 h reaction. 
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We also have examined functional group tolerance in presence of the aldehydes. 
Through the investigation of these studies, functional group tolerances using these 
conditions were found to be high. For example, we found that para-silyl-protected 
hydroxybenzaldehyde 17m converted to the desired homoaldol equivalent product 30m 
in 99% yield (Table 1.2) and also 3,4-(methylenedioxy)benzaldehyde 17n proceeded 
efficiently to afford the desired homoaldol equivalent product 30n  in 96% yield. 
Interestingly, functional group tolerance of other moieties such as ketone 17j, ester 17k, 
and nitrile 17l lead to diminished but still synthetically acceptable yields (70%, 71%, and 
75% yields, respectively (Table 1.2)).20  
 
Scheme 1.8. Proposed Mechanism of the Homoaldol Equivalent Reaction 
2 Cr(III)
2 Cr(II)
OCr(III)
Ph
H
OAc
TMSCl
OTMS
Ph
OAc
H
Mn(0)
Mn(II)
Br OAc
O
Ph H
17a 29c
29e
29f
29d
1 Cr(III)+1 Cr(I)
O
Me O
Cr(III)
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Although more comprehensive studies are required to describe a mechanism of 
the homoaldol equivalent reaction and the transition state arrangement, we proposed a 
plausible reaction mechanism based on the observed experimental results and literature 
precedent.19 First, chromium (III) is being reduced with Mn (0) to chromium (II), which 
undergoes redox interconversion to generate chromium (III) and chromium (I),21-23 in 
which chromium (I) undergoes oxidative addition with 3-bromopropenyl acetate 29c to 
form organochromium complex 29d. Second, the organochromium complex 29d 
undergoes addition to benzaldehyde 17a to afford organochromium complex 29e. 
Finally, transmetallation of organochromium complex 29e with TMSCl generates   
TMS-protected homoaldol equivalent adduct 29f (Scheme 1.8). 
In all cases, we have observed only the desired homoaldol adducts without 
formation of possible 1,2-oxygenated regioisomeric product 30ab and the trans-vinyl 
acetate product 30aa. We believe that these observations of highly regio-and chemo-
selective reaction can be explained by a transition state arrangement as describe in 
Scheme 1.9, in which the formation of a 5-membered ring chelate between the 
chromium center and the acetate subunit as part of a well-established 6-membered ring is 
crucial for explaining regio- and chemo-selective C–C bond formation. When the acetate 
subunit is located at equatorial position on 6-membered ring which could respond to 
unobserved trans-vinyl acetate product 30aa, the formation of a 5-membered ring 
chelate between the chromium center and the acetate subunit is not plausible because the 
acetate subunit is not reachable to chelate chromium center. 
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Scheme 1.9. Proposed 6-membered Ring Transition State Arrangement 
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H
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O
Me
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OH
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O O
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The 5-membered chelate ring formation between the chromium center and the 
acetate subunit is more stable complex than 7-memberd chelate ring formation 
corresponding to unobserved 1,2-oxygenated regioisomeric product 30ab. Accordingly, 
the cis-alkene geometry and regiochemistry of the homoaldol addition products were 
rationalized by this transition state arrangement (Scheme 1.9).20 
 Due to the potential application of this process for the generation of chiral 
building blocks applicable in total synthesis, we explored larger-scale reactions 
described in Table 1.3. With use of 2 mmol of benzaldehyde 17a, the reaction proceeded 
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smoothly to afford the homoaldol adducts 30a in 99% yield  (Table 1.3, entry 2). When 
5 mmol of benzaldehyde 17a was subjected to the standard reaction, low yield of 
product (51%) obtained (Table 1.3, entry 3). For larger reaction scales, the use of freshly 
washed Mn0 with HCl, which could eliminate any presence of MnO2, was required to 
obtain high yields. On 5 mmol (Table 1.3, entry 4) or 20 mmol (Table 1.3, entry 5) scale 
reactions with fresh Mn0, the isolated yield of product 30a is 90% or 85%, respectively 
(Table 1.3).  
 
Table 1.3. Large Scale Reaction of Homoaldol Equivalent Reactiona 
entry mmol (17a) isolated yield (%)b
17a 29c 30a
 CrCl3 (10 mol%)
 Et3N (15 mol%) 
TMSCl/Mn0 (2 equiv )+
THF, 20 h then TBAF
1
2
3
5c
1
2
5
20
99
99
51
85
Ph
OH
OAc
Br
OAc
O
HPh
4c 5 90
 
a Reactions were performed using 29c (2 equiv), aldehydes 17a (1 
equiv), CrCl3 (10 mol%), Mn0 (2 equiv), Et3N (15 mol%), and 
TMSCl (2 equiv) in THF at rt for 20 h, quenched with saturated 
aqueous NaHCO3 solution, and deprotected with TBAF. b Isolated 
yield. c Entry 1, 2, and 3 followed GP1. Entry 4 and 5 used 
activated Mn0 (325 mesh) that was prepared by sequentially 
washing with 5% HCl, EtOH, and Et2O, and then dried under high 
vacuum and used according to GP1.  
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We next performed hydrolysis and reduction of the homoaldol equivalent 
adducts to afford diol 31 and lactol 32 respectively (Scheme 1.10). Treatment of the 
homoaldol equivalent adducts with NaBH4 in NaOH provided diol 31 in excellent yield 
(99%). Mild hydrolysis condition (LiOH/MeOH) of the homoaldol equivalent adducts 
provides the formal homoaldol product, which is isolated after spontaneous cyclization 
to lactol 32 in quantitative yield.20 
 
Scheme 1.10. Hydrolysis and Reduction of Homoaldol Equivalent Product 30a 
32
31
NaBH4 
NaOH/H2O
30a
>99%
99%
OPh OH
Ph
OH
OAc Ph
OH
OH
Ph
H
OH
O
formal
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LiOH
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1.4 Functionalization of Homoaldol Equivalent Products and Stereochemical 
Assignment 
Surprisingly, hydroxyl-directed5 epoxidations and cyclopropanations of vinyl 
acetates have not been previously reported. Hydroxyl-directed epoxidations of 
homoallylic alcohols were successful only for specific types of homoallylic alcohols. For 
example, hydroxyl-directed epoxidation of homoallylic alcohols24 in cyclic systems have 
proven possible (Scheme 1.11), yet acyclic homoallylic alcohols have not been 
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successful in the hydroxyl-directed epoxidation. Directed-epoxidation of homoallylic 
alcohols bearing alkene α-stereocenters exhibit high stereoselectivity (Scheme 1.11).25 
To the best of our knowledge, we reported the first highly diastereoselective 
epoxidations of acyclic homoallylic alcohols where no α-stereocenters of the olefins are 
present, providing over 90% de. 
 
Scheme 1.11. Hydroxyl-Directed Epoxidation of Cyclic Homoallylic Alcohols  
OH Mo(CO)6 (5 mol%)
TBHP, toluene, !, 3 h 
90%
OH
O
Me
Me
OH
MeMe
VO(acac)2 (5 mol%)
TBHP, CH2Cl2, rt, 16 h 
97%, dr>400:1 Me
Me
OH
MeMe
O
 
 
 
To demonstrate the value of the proximal hydroxyl and vinyl acetate groups of 
the homoaldol products, conversion of homoaldol equivalent adducts into very valuable 
compounds was pursued. When the homoaldol adducts were treated with m-CPBA, an 
equal ratio of diastereomeric epoxides was obtained. As a result, we explored transition 
metal catalyzed epoxidation of homoallylic alcohols.26 We employed VO(Oi-Pr)3 (2 
mol%) as a catalyst for directed epoxidation of homoallylic alcohols with hydrogen 
peroxides such as TBHP (70% in water), CHP, and TBHP (5.5 M in decane) but the 
highest yield from the  catalyst was less than 50% (dr = 10:1). The preliminary results of 
directed-epoxidation of homoallylic alcohols with vanadium catalyst provided promising 
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results in selectivity (dr = 10:1) but the chemical yield was low. As a result, we utilized 
VO(acac)2 (2 mol%) and TBHP (5.5M in decane). The directed epoxidation with 
VO(acac)2 (2 mol%) and TBHP (2 mmol) installed the epoxide/acetal, providing the 
1,2,4-oxygenated α-acetoxy-δ-hydroxy α,β-epoxide 33a in 82% yield as primarily the 
syn diastereomer (dr = 13:1, Table 1.4, entry 1). With the optimal conditions in hand, the 
substrate scope of the hydroxyl-directed epoxidation of homoallylic alcohol was 
examined. Highly selective epoxidation of homoallylic alcohols was demonstrated in the 
reaction of hydroxy phenyl butenyl acetate 30a (Table 1.4, entry 1) as well as 
epoxidation of bromophenyl hydroxy butenyl acetate 30e (Table 1.4, entry 2) and 
cyclohexyl hydroxy buenyl acetate 30i (Table 1.4, entry 3), providing high yield and 
selectivity of 80% yield (dr = >15:1) and 82% (dr = 10:1) respectively. This hydroxyl-
directed epoxidation of homoallylic alcohols allows us to approach β-hydroxy epoxide in 
stereoselectivity (dr = >15:1, Table 1.4, entry 2).20 
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Table 1.4. Hydroxyl-Directed Epoxidation of Vinyl Acetatesa 
OH
OAc
OH
OAc
Br
OH
OAc
30a
30e
30i
OH
OAc
OH
OAc
Br
OH
OAc
33a, 80%, drc=13:1
33e, 80%, dr=>15:1
33i, 82%, dr=10:1
O
O
O
VO(acac)2 (2 mol%) 
TBHP (2 equiv)
30 33CH2Cl2, 0 °C to rt, 15 h
R
OH
OAc
R
OH
OAc
O
SM productb
 
a Reagents: VO(acac)2 (2 mol%), adducts 30 (1 mmol), TBHP 
(5.5 M solution) (2 mmol) in CH2Cl2 at rt for 15 h. b Isolated 
yield. c dr (syn:anti) was determined by 1H NMR spectroscopy. 
 
In order to confirm the syn-epoxide products, we employed [13C] acetonide 
methods previously developed by Rychnovsky. Rychnovsky and co-workers have 
established a general method to determine stereochemistry of syn- and anti-1,3-diol 
acetonides by 13C chemical shifts of acetyl methyl groups.27 The epoxide product 33a 
was treated with LiBH4 affording triol 33b in which the primary alcohol was protected 
with acetyl chloride, providing 33c (Scheme 1.12). The 1,3-diol 33c was converted into 
acetonide 33d.18 The vicinal methyl groups of the syn-1,3-diol acetonide resulted in a 
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diastereotopic group posessing different chemical shifts for the two methyl groups (δ = 
30.2, 21.0 ppm), confirming the syn-epoxide product 33a. 
 
Scheme 1.12. Stereochemical Analysis of Hydroxyl-Directed Epoxides 
Ph
OH
OAc
O
Ph
O
OAc
O
CH3H3C
Ph
OH OH
Ph
OH OHAcCl, NEt3
PPTS
DMP
33b 33c 33d33a
OH
acetone, !CH2Cl2
0 °C to rt
 LiBH4
Et2O
0 °C to rt
OAc
 
 
 With these promising results using hydroxyl-directed epoxidation of homoallylic 
alcohols, we were interested in studying the stereoselective conversion of the homoaldol 
adducts to cyclopropane subunits. This was of interest not only due to the challenge of 
selective cyclopropation of homoallylic alcohols but also their presence in a wide variety 
of natural products and biological active compounds.28 
 Since the pioneering research by Simmons and Smith for cyclopropanation was 
reported29,30 it has became the most widely used reaction of three-membered ring 
synthesis, and employs Zn(Cu)/diiodomethane reagent. Recently, several alternative 
methods for the generation of the reactive reagent (RZnCH2I) in cyclopropanation were 
introduced by Denmark31 (ClZnCH2I) and Shi (CF3CO2ZnCH2I) (Scheme 1.13).32 
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Scheme 1.13. Cyclopropanation of Olefins 
CH2I2, Zn(Cu)
Et2O, 35 °C, 4 h
48%
OH
Et2Zn, ClCH2I
DCE, 0 °C, 30 min
93%, 99% de
OH
Ph
Me
CF3CO2ZnCH2I 
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77%
Ph
Me
 
 
 Results form examination of stereoselective cyclopropanation of the homoaldol 
equivalent adducts employing the Simmons-Smith reagent (IZnCH2I) were rather 
disappointing, providing 40% (dr = 1.6:1). When the Denmark reagent (ClZnCH2I) was 
employed, the product yield was improved (73%), yet selectivity was still low (dr = 
1.6:1). Remarkably, Shi’s cyclopropanation reagent (CF3CO2ZnCH2I) afforded the best 
result for selective cyclopropanation (95%, dr = 6.6:1, Table 1.5, entry 1) of homoallylic 
alcohols. 20 
With these optimized reaction conditions in hand, the substrate scope was 
examined. The hydroxyl-directed cyclopropanation of homoallylic alcohols proceeded 
well in both aromatic and aliphatic homoaldol adducts, yet the best yield (95%, Table 
1.5, entry 1) and selectivity (dr = 6.6:1, Table 1.5, entry 1) were derived from the parent 
homoaldol adduct 30a. We observed a noticeable decrease of selectivity from 2-
bromophenyl hydroxyethyl cyclopropyl acetate 34e (dr = 3.8:1, Table 1.5, entry 3) 
probably due to interaction between the zinc reagent and halogen of the olefin 30e. To 
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best of our knowledge, this is the first highly syn-selective cyclopropanation of 
homoallylic alcohols in acyclic systems leading to excellent yields (95%) and selectivity 
(dr = 6.6:1) even though selective cyclopropantions of allylic alcohols33 and homoallylic 
alcohols in cyclic system have been previously reported.34 
 
Table 1.5. Hydroxyl-Directed Cyclopropanation of Vinyl Acetatesa 
OH
OAc
OH
OAc
Br
OH
OAc
30a
30e
30i
OH
OAc
OH
OAc
Br
OH
OAc
34a, 95%, drc=6.6:1
34e, 80%, dr=3.8:1
34i, 88%, dr=6:1
SM productb
Et2Zn (2 equiv)
CH2I2 (4 equiv)
30 34
TFA (2 equiv) 
CH2Cl2, 0 °C, 4 h
R
OH
OAc
R
OH
OAc
OH
OAc
CH3
30d
OH
OAc
CH3
34d, 84%, dr=5:1
 
aAll reactions were performed using Et2Zn (1 mmol), CH2I2 (2 
mmol), TFA (1 mmol), olefin 30 (0.5 mmol) in CH2Cl2 at 0 °C 
for 4 h. b Isolated yield. c dr (syn:anti) was determined by HPLC.  
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The stereochemical outcome of the hydoxyl-directed cyclopropanation was 
rationalized by the use of NOE measurements after cyclization of the diol intermediate 
34b to bicyclic cyclopropane 34c (Scheme 1.14). NOE data strongly supports the 
conclusion that cyclopropanation of the homoaldol adducts was directed by the hydorxyl 
group (Table 1.6).20 
 
Scheme 1.14. Stereochemical Analysis of Hydroxyl-Directed Cyclopropanation Product 
Ph
OH
OH
34c34a
O
O
Ph
H3C CH3
Ph
OH
OAc
34b
PPTS
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Table 1.6. Key NOE Enhancements in 34c 
Irradiated H Observed H % nOe
A
A
B1
F
E
CE
3.1
A H
3.1
2.9
2.5
5.0
F2
O O
Ph
HA
MeF2
MeF1
HB2
HB1
HE
HC
2.5%
3.1%
5.0%
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1.5 Asymmetric Homoaldol Equivalent Reactions 
 Although chromium-catalyzed enantioselective addition of allylic bromides to 
ketones35 and aldehydes36 to afford homoallylic alcohols has been well studied, 
asymmetric homoaldol reactions remain in difficult tasks reported in few cases.12,13 For 
example, Hoppe reported asymmetric homoaldol equivalent reaction employing chiral 
diamine (–)-sparteine and s-BuLi for stereoselective lithiation of prochiral butenyl 
carbamates which underwent transmetallation with Ti(Oi-Pr)4 generating titanium 
complex that added to aldehydes to afford enantioselective synthesis of homoaldol 
products13. This method, however, limited in carbamate substrates and utilized 
stoichiometric amount of titanium reagents. 
 Therefore, we desired to explore asymmetric homoaldol equivalent reactions 
employing a variety of chiral ligands. The tridentate bis(oxazolinyl)carbazole ligands 
have been successfully applied for the asymmetric catalysis of Nozaki-Hiyama 
methallylation and allylation of aldehydes.37 We employed tridentate 
bis(oxazolinyl)carbazole ligands, PyBox ligands, and phosphoramidite ligands for the 
asymmetric homoaldol reactions described in Table 1.7. The results of asymmetric 
homoaldol reactions employing the ligands, however, show low enantioselectivity 
(Table 1.7). Among the ligands (Table 1.7), the [PyBoxi-Pr] ligand exhibited the highest 
enantioselectivity (11% ee).  
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Table 1.7. Asymmetric Homoaldol Equivalent Reactions Employing Carbazole and 
PyBox Ligandsa,b 
1% ee
0% ee7% ee
N N
N
N
OO
N
PhPh
N
N
OO
N
i-Pri-Pr
11% ee
N
O
N
O
BnBn
2% ee
O
O
P NH
CH3
Ph
O
O
P N
CH3
CH3
Ph
Ph
0% ee
NN
OH HO
CH3 H3C
CH3 H3C
CH3 CH3
4% ee
N
H
Ph Ph
O
N N
O
iPr iPr
4% ee
N
H
Ph Ph
O
N N
O
Bn Bn
9% ee
N
H
Ph Ph
O
N N
O
Ph Ph
9% ee
N
H
O
N N
O
Ph Ph
7% ee
Br
OAc
 CrCl3 (10 mol%), Et3N (15 mol%) 
ligand (10 mol%), TMSCl/Mn0 (2 equiv )
R
OH
OAc
+
O
R
29c (E/Z=2:1)17 Z-30
H
THF, 20 h, then TBAF
 
a Reactions were performed using 29c (0.64 mmol), aldehydes 17 (0.32 mmol), CrCl3 (0.032 mmol), Mn0 
(0.64 mmol), Et3N (0.048 mmol), ligand (0.032 mmol), and TMSCl (0.64 mmol) in 2 mL THF at rt for 20 
h, quenched with saturated aqueous NaHCO3 solution, and deprotected with TBAF. b Enantiomeric excess 
was determined by Chiral HPLC: Chiralcel® OD-H column (hexane/i-PrOH = 95/5), 1.0 mL/min, 254 nm, 
major diastereoisomer tR = 16.0 min, and minor diastereoisomer tR = 19.0 min.  
 
 We then utilized DABN38 (Diamino-1,1′-binaphthalene) and BINOL39 
(Binaphthalene-2,2′-diol) derivative ligands for the asymmetric homoaldol reactions. 
The results employing DABN and BINOL derivative ligands are described in Table 1.8. 
The DABN and BINOL derivative ligands were not effective ligands for asymmetric 
homoaldol reactions providing low enantioselectivity (Table 1.8). 
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Table 1.8. Asymmetric Homoaldol Equivalent Reactions Employing DABN and BINOL 
derivative Ligandsa,b 
N
H
H
N
N
N
7% ee
NH2
NH2
3% ee 10% ee
OH
OH
3% ee CF3
CF3
CF3
CF3
OH
OH
7% ee
i-Pr
i-Pr i-Pr
i-Pr
i-Pr i-Pr
N
HO
CH3
N
HO
CH3
OH
OH
CH3
CH3
CH3
CH3
3% ee
5% ee
NH2
NH
O2S
i-Pr
i-Pr
i-Pr
N
H
H
N
SO2
SO2
Me
Me
Br
OAc
 CrCl3 (10 mol%), Et3N (15 mol%) 
ligand (10 mol%), TMSCl/Mn0 (2 equiv )
R
OH
OAc
+
O
R
29c (E/Z=2:1)17 Z-30
H
THF, 20 h, then TBAF
 
a Reactions were performed using 29c (0.64 mmol), aldehydes 17 (0.32 mmol), CrCl3 (0.032 mmol), Mn0 
(0.64 mmol), Et3N (0.048 mmol), ligand (0.032 mmol), and TMSCl (0.64 mmol) in 2 mL THF at rt for 20 
h, quenched with saturated aqueous NaHCO3 solution, and deprotected with TBAF. b Enantiomeric excess 
was determined by Chiral HPLC: Chiralcel® OD-H column (hexane/i-PrOH = 95/5), 1.0 mL/min, 254 nm, 
major diastereoisomer tR = 16.0 min, and minor diastereoisomer tR = 19.0 min.  
 
 Oxazoline-containing ligands36 and sulfonamide ligands40 have been used in the 
enantioselective Nozaki-Hiyama-Kishi reaction. Accordingly, we have employed the 
ligands for the asymmetric homoaldol equivalent reactions described in Table 1.9. 
However, we obtained poor enantioselectivity of homoaldol equivalent products from 
these ligands.  
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Table 1.9. Asymmetric Homoaldol Equivalent Reactions Employing Oxazoline and 
Sulfonamide Ligandsa,b 
0% ee 6% ee 4% ee
Me
HN
O
N
Bn
SO2
2% ee 2% ee
4% ee
O
N
i-Pr
NH
O2S
Bn
Me
Me Me
O
N
i-Pr
NH
O2S
Bn
Me
Me Me
O
N
i-Pr
NH
O2S
Bn
Me
Me
O
N
i-Pr
NH
O2S
Bn
N
HN
Me
O
N
SO2
Me
i-Pr
HN
Me
O
N
SO2
Bn
MeMe
Me
2% ee
HN
Me
O
N
SO2
i-Pr
MeMe
Me
4% ee
5% ee
N
O
N
H
i-Pr
Bn
O
N
Boc
N
H
O
N
Bn
Fmoc
7% ee
i-Pr
Br
OAc
 CrCl3 (10 mol%), Et3N (15 mol%) 
ligand (10 mol%), TMSCl/Mn0 (2 equiv )
R
OH
OAc
+
O
R
29c (E/Z=2:1)17 Z-30
H
THF, 20 h, then TBAF
 
a Reactions were performed using 29c (0.64 mmol), aldehydes 17 (0.32 mmol), CrCl3 (0.032 mmol), Mn0 
(0.64 mmol), Et3N (0.048 mmol), ligand (0.032 mmol), and TMSCl (0.64 mmol) in 2 mL THF at rt for 20 
h, quenched with saturated aqueous NaHCO3 solution, and deprotected with TBAF. b Enantiomeric excess 
was determined by Chiral HPLC: Chiralcel® OD-H column (hexane/i-PrOH = 95/5), 1.0 mL/min, 254 nm, 
major diastereoisomer tR = 16.0 min, and minor diastereoisomer tR = 19.0 min.  
 
 When chiral diamine ligands41 were employed for the asymmetric homoaldol 
equivalent reactions, we obtained the homoaldol product in 25% ee (Table 1.10). It was 
observed that bulky substituents such as iso-propyl group on the ligand caused an 
increase in enantioselectivity of the homoaldol equivalent products (Table 1.10).  
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 Based on these results, sulfonamide chiral diamine ligands were the most 
effective ligands for the asymmetric homoaldol equivalent reactions yet more 
comprehensive studies toward the asymmetric homoaldol equivalent reactions are 
necessary to improve enantioselectivity. 
 
Table 1.10. Asymmetric Homoaldol Equivalent Reactions Employing Chiral Diamine 
Ligandsa,b 
Ph
HNNH
Ph
SO2O2S
4% ee
Ph
HNNH
Ph
SO2O2S
25% ee
Ph
HNNH
Ph
SO2O2S
Ph
HNNH
Ph
SO2O2S
N N
4% ee
F3C
CF3F3C
CF3
i-Pr
i-Pr
i-Pr i-Pr
i-Pr
i-Pr
Me
Me
Me
Me
Me
Me
3% ee
Ph
HNNH
Ph
SO2O2S
OMeMeOOMeMeO
3% ee
NH HN
N N
6% ee1% ee
HNNH
OO
P(Ph)2 (Ph)2P
3% ee
Ph
HNNH
Ph
SO2O2S
HOOH
Cl
Cl
Cl
Cl
NN
HO tBu
tBu
OH
tBu
tBu
6% ee
Br
OAc
 CrCl3 (10 mol%), Et3N (15 mol%) 
ligand (10 mol%), TMSCl/Mn0 (2 equiv )
R
OH
OAc
+
O
R
29c (E/Z=2:1)17 Z-30
H
THF, 20 h, then TBAF
 
a Reactions were performed using 29c (0.64 mmol), aldehydes 17 (0.32 mmol), CrCl3 (0.032 mmol), Mn0 
(0.64 mmol), Et3N (0.048 mmol), ligand (0.032 mmol), and TMSCl (0.64 mmol) in 2 mL THF at rt for 20 
h, quenched with saturated aqueous NaHCO3 solution, and deprotected with TBAF. b Enantiomeric excess 
was determined by Chiral HPLC: Chiralcel® OD-H column (hexane/i-PrOH = 95/5), 1.0 mL/min, 254 nm, 
major diastereoisomer tR = 16.0 min, and minor diastereoisomer tR = 19.0 min.  
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1.6 Conclusion 
We have reported regioselective, catalytic homoaldol equivalent reactions of 3-
bromo vinyl acetate with aldehydes under Cr(III)-Mn(0) redox condition. This homoaldol 
equivalent reaction allows us to access to the 1,4-oxygenated compounds that are not 
possible by a conventional aldol processes. Mild hydrolysis of the vinyl acetate and 
reduction conditions of the homoaldol adducts generated the diols and lactols in high 
yield (99%). Large scale reactions which are often a challenging process in catalytic 
reactions still led to high yields (20 mmol scale, 85%). Further manipulation of the 
homoaldol equivalent adducts with VO(acac)2 (2 mol%) and TBHP provided 
stereoselective β-hydroxy epoxides with excellent selectivity (dr = >15:1). Upon 
treatment of the homoaldol adducts with Shi’s cyclopropanation reagent 
(CF3CO2ZnCH2I), high stereoselective cyclopropanation was observed in high 
selectivity (dr = 6.6:1). We also have explored asymmetric homoaldol equivalent 
reactions employing chiral diamine ligands providing 25% ee. 
 
 
 
 
 
 
 
 
  
32 
1.7 Experimental Procedure 
1.7.1 General Information 
All reactions were carried out under an argon atmosphere in oven-dried 
glassware and with magnetic stirring bar. Dry THF was purified by passing through 
alumina under argon. All commercially obtained reagents were used as received.  
Purification of reaction products was carried out by flash column 
chromatography using silica gel 60 (230-400 mesh). Analytical thin layer 
chromatography was performed on 1.00 mm glass-backed silica gel 60-F plates. 
Visualization was performed with UV light or KMnO4 stain solution. Concentration in 
vacuo refers to the removal of volatile solvent using a rotary evaporator attached to a dry 
diaphragm pump (10-15 mm Hg) and pumping to a constant weight with an oil pump 
(<300 mTorr). Heating was accomplished using silicone oil bath.  Temperature was 
controlled by a temperature controller.  
1H NMR spectra were recorded on a Varian Inova 300 (at 300 MHz) or a Varian 
Mercury 300 (at 300 MHz) NMR and are recorded relative to Me4Si (δ 0.0 ppm). 1H 
NMR coupling constants (J) are reported in Hertz (Hz) and multiplicities are indicated as 
follows: s (singlet), d (doublet), t (triplet), m (multiplet). Proton-decoupled 13C NMR 
spectra were recorded on Varian Inova 300 (at 75 MHz) or a Varian Mercury 300 (at 75 
MHz) and are reported relative to CDCl3 (δ 77.16 ppm). High-resolution mass spectra 
(HRMS) were obtained at TAMU. Infrared spectra were recorded on a Bruker Tensor 27 
spectrometer as a thin film on NaCl plates.  
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1.7.2 General Procedure 1 (GP1) of Homoaldol Equivalent Reaction 
CrCl3, Mn
Et3N, TMSCl
R
OH
OAc
+
O
R
17 29c 30
THF, 20 h
then TBAFH
Br
OAc
 
 
To 2 dram vial was added CrCl3 (5 mg, 0.032 mmol, 0.1 equiv) and Mn(0) (325 
mesh) (35 mg, 0.64 mmol, 2 equiv). The vial was fitted with a Teflon cap, purged with 
argon, charged with THF (2.0 mL), and allowed to stir for 20 min at rt (18 °C to 22 °C). 
After 20 min, Et3N (5 mg, 0.048 mmol, 0.15 equiv) and TMSCl (70 mg, 0.64 mmol, 2 
equiv) were added to the reaction mixture.  After stirring for 20 min, the reaction color 
changed to a deep dark color. After 20 min, 3-bromopropenyl acetate 29c (115 mg, 0.64 
mmol, 2 equiv) was added and the reaction mixture stirred for 40 min. After 40 min, 
aldehyde 17 (0.32 mmol, 1 equiv) was added and the mixture was allowed to stir at rt 
(18 °C to 22 °C) for 20 h. The reaction was quenched with saturated aqueous NaHCO3 
solution (1.5 mL). After stirring for 30 min, the mixture was passed through a Celite® 
plug, eluting with CH2Cl2. The layers were separated and the aqueous layer was 
extracted with CH2Cl2. The combined organic layers were dried over MgSO4, filtered, 
and then treated directly with 1 mL TBAF (1 mol in THF). The reaction mixture was 
quenched with saturated aqueous NaHCO3 solution, extracted with CH2Cl2, dried over 
MgSO4, and concentrated under reduced pressure. Purification was accomplished by 
flash column chromatography. 
 
  
34 
1.7.3 General Procedure 2 (GP2) of Hydroxyl-Directed Epoxidation 
R
OH
OAc
VO(acac)2 (2 mol%), TBHP (2 equiv)
R
OH
OAc
O
30 33
CH2Cl2, 0 °C to rt, 15 h
 
 
    A 10 mL round bottom flask was charged with VO(acac)2 (2 mol%, 0.02 equiv) 
in a dry box. To the flask was added CH2Cl2 (5 mL) in an ice bath and a solution of the 
appropriate olefin 30 (1 mmol, 1 equiv) in CH2Cl2 (1 mL). To this solution was added 
TBHP (5.5 M solution in decane) (2 mmol, 2 equiv) over 1 h by syringe pump at 0 °C 
and then the reaction mixture was allowed to warm up to rt (18 °C to 22 °C) and stirred 
for 15 h. After 15 h, the reaction mixture was passed through a Celite® plug eluting with 
CH2Cl2. The layers were separated and the aqueous layer was extracted with CH2Cl2. 
The combined organic layers were dried over MgSO4, filtered, and concentrated under 
reduced pressure. Purification was accomplished by flash column chromatography. 
 
1.7.4 General Procedure 3 (GP3) of Hydroxyl-Directed Cyclopropanation 
R
OH
OAc
Et2Zn, CH2I2, TFA
R
OH
OAc
30 34
CH2Cl2, –78 °C to 0 °C, 4 h
 
 
     To a solution of Et2Zn (1 mmol, 2 equiv) in CH2Cl2 (3 mL) was added CH2I2 (2 
mmol, 4 equiv) dropwise at –78 °C and the reaction mixture was allowed to warm up to 
0 °C and stirred for 15 min at 0 °C, then TFA (1 mmol, 2 equiv) was added to the 
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reaction mixture and stirred for another 15 min at 0 °C. To the resulting mixture was 
added the appropriate olefin 30 (0.5 mmol, 1 equiv) in CH2Cl2 (1 mL) over 20 min and 
the resulting mixture was stirred at 0 °C for 4 h. After 4 h, the reaction mixture was 
quenched with saturated aqueous NH4Cl solution at 0 °C. The layers were separated and 
the aqueous layer was extracted with CH2Cl2. The combined organic layers were dried 
over MgSO4, filtered, and concentrated under reduced pressure. Purification was 
accomplished by flash column chromatography. 
 
1.7.5 General Procedure 4 (GP4) of Epoxidation 
R
OH
OAc
m-CPBA
R
OH
OAc
O
30 33
R
OH
OAc
O
+
CH2Cl2, 0 °C to rt, 10 h
 
 
    To a solution of the appropriate olefin 30 (0.1 mmol, 1 equiv) in CH2Cl2 (1 mL) 
was added m-CPBA (0.12 mmol, 1.2 equiv) dropwise at 0 °C and then the resulting 
mixture was stirred for 1 hour at the same temperature. The reaction mixture was warm 
up to rt (18 °C to 22 °C) and stirred for 10 h. The reaction mixture was washed with 
saturated aqueous Na2SO4. The organic layer was extracted with saturated aqueous 
NaHCO3, dried over MgSO4, and concentrated under reduced pressure. Purification was 
accomplished by flash column chromatography.  
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1.7.6 General Procedure 5 (GP5) of Cyclopropanation 
R
OH
OAc
Et2Zn, ICH2Cl
R
OH
OAc30
34
R
OH
OAc
+
CH2Cl2,  0 °C, 4 h
 
 
    To a solution of Et2Zn (1 mmol, 2 equiv) in CH2Cl2 (3 mL) was added ICH2Cl (2 
mmol, 4 equiv) dropwise at 0 °C and the reaction mixture was stirred for 15 min at 0 °C. 
To the resulting mixture was added appropriate olefin 30 (0.5 mmol, 1 equiv) in CH2Cl2 
(1 mL) over 20 min and the resulting mixture was stirred at 0 °C for 4 h. The reaction 
mixture was quenched with saturated aqueous NH4Cl solution at 0 °C. The layers were 
separated and the aqueous layer was extracted with CH2Cl2. The combined organic 
layers were dried over MgSO4, filtered, and concentrated under reduced pressure. 
Purification was accomplished by flash column chromatography.  
 
 (Z)-4-Hydroxy-4-phenylbut-1-enyl acetate (30a). Benzaldehyde 
17a (0.32 mmol, 34 mg, 1.0 equiv) and 3-bromoprop-1-enyl acetate 
29c (115 mg, 0.64 mmol, 2.0 equiv) were subjected to the reaction conditions described 
in GP1. Flash column chromatography with 1:3 EtOAc/hexanes provided a colorless oil 
of 30a (66 mg, 99%). Rf = 0.25; IR (film, cm-1): 3434 (br), 3031, 2907, 1750; 1H NMR 
(300 MHz, CDCl3) δ 7.39-7.25 (m, 5H), 7.07 (d, J = 6.3, Hz, 1H), 4.90 (q, J = 7.5 Hz, 
1H), 4.71 (t, J = 6.5 Hz, 1H), 2.70-2.54 (m, 2H), 2.30 (bs, 1H), 2.09 (s, 3H) ; 13C NMR 
OH
OAc
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(75 MHz, CDCl3) δ 168.0, 143.8, 135.9, 128.4 (2), 127.7, 125.8 (2), 109.3, 73.5, 34.2, 
20.7; HRMS (ESI) calcd for C12H14O3 [M+Li]+: 213.1103; found: 213.1119 
 
 (Z)-4-Hydroxy-4-(4-methoxyphenyl)but-1-enyl acetate 
(30b). 4-Methoxybenzaldehyde 17b (0.32 mmol, 44 mg, 1.0 
equiv) and 3-bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 equiv) were 
subjected to the reaction conditions described in GP1. Flash column chromatography 
with 1:3 EtOAc/hexanes provided a colorless oil of 30b (68 mg, 90%). Rf = 0.13; IR 
(film, cm-1): 3478 (br), 3005, 2940, 2839, 1755, 1610; 1H NMR (300 MHz, CDCl3) 
δ 7.29 (d, J = 9.13 Hz, 2H), 7.09 (d, J = 6.3, Hz, 1H), 6.88 (d, J = 9.13 Hz, 2H), 4.89 (q, 
J = 7.5 Hz, 1H), 4.69 (t, J = 6.5 Hz, 1H), 3.8 (s, 3H), 2.69-2.54 (m, 2H), 2.11 (s, 3H), 
1.99 (bs, 1H); 13C NMR (75 MHz, CDCl3) δ 168.0, 159.2, 135.9 (2), 127.2 (2), 113.8 
(2), 109.5, 73.3, 55.4, 34.2, 20.8; HRMS (ESI) calcd for C13H16O4 [M+Li]+: 243.1209; 
found: 243.1185. 
 
(Z)-4-Hydroxy-4-(4-(trifluoromethyl)phenyl)but-1-enyl 
acetate (30c). 4-Trifluoromethylbenzaldehyde 17c (0.32 
mmol, 56 mg, 1.0 equiv) and 3-bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 
equiv) were subjected to the reaction conditions described in GP1. Flash column 
chromatography with 1:4 EtOAc/hexanes provided a colorless oil of 30c (80 mg, 91%). 
Rf = 0.21; IR (film, cm-1): 3446 (br), 3102, 3067, 2928, 1755, 1670, 1619; 1H NMR (300 
MHz, CDCl3) δ 7.61 (d, J = 8.2 Hz, 2H), 7.49 (d, J = 8.2, Hz, 2H), 7.12 (d, J = 6.3, Hz, 
OH
OAc
MeO
OH
OAc
F3C
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1H), 4.89 (q, J = 7.5 Hz, 1H), 4.80 (t, J = 6.5 Hz, 1H), 2.65-2.58 (m, 2H), 2.16 (bs, 1H), 
2.09 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 167.9, 148.2, 136.6, 126.2 (3), 125.5 (3), 
108.5, 73.0, 34.5, 20.7; HRMS (ESI) calcd for C13H13F3O3 [M+Li]+: 281.0977; found: 
281.0960. 
 
 (Z)-4-Hydroxy-4-o-tolylbut-1-enyl acetate (30d). 2-
Methylbenzaldehyde 17d (0.32 mmol, 38 mg, 1.0 equiv) and 3-
bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 equiv) were 
subjected to the reaction conditions described in GP1. Flash column chromatography 
with 1:5 EtOAc/hexanes provided a colorless oil of 30d (57 mg, 82%). Rf = 0.22; IR 
(film, cm-1): 3434 (br), 3061, 3025, 2928, 1755; 1H NMR (300 MHz, CDCl3) δ 7.50 (d, J 
= 7.5 Hz, 1H), 7.25-7.09 (m, 4H), 5.02-4.94 (m, 2H), 2.59-2.54 (m, 2H), 2.34 (s, 3H), 
2.30 (bs, 1H), 2.16 (bs, 1H), 2.09 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 168.2, 141.2, 
136.1, 134.6, 130.6, 127.6, 126.5, 125.3, 109.8, 70.2, 33.3, 20.9, 19.2; HRMS (ESI) 
calcd for  C13H16O3 [M+Li]+: 227.1259; found: 227.1242. 
 
 (Z)-4-(2-Bromophenyl)-4-hydroxybut-1-enyl acetate (30e). 2-
Bromobenzaldehyde 17e (0.32 mmol, 59 mg, 1.0 equiv) and 3-
bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 equiv) were subjected to the 
reaction conditions described in GP1. Flash column chromatography with 1:3 
EtOAc/hexanes provided a colorless oil of 30e (70 mg, 78%). Rf = 0.20; IR (film, cm-1): 
3446 (br), 3064, 2922, 1755; 1H NMR (300 MHz, CDCl3) δ 7.59-7.11 (m, 5H), 5.15 (m, 
OH
OAc
CH3
OH
OAc
Br
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1H), 5.00 (q, J = 7.5 Hz, 1H), 2.74-2.65 (m, 1H), 2.60-2.50 (m, 1H), 2.11 (s, 4H); 13C 
NMR (75 MHz, CDCl3) δ 168.1, 142.7, 136.5, 132.8, 129.2, 127.8, 127.6, 122.0, 109.2, 
72.4, 32.7, 20.9; HRMS (ESI) calcd for  C12H13BrO3 [M+Li]+: 291.0208; found: 
291.0143. 
 
 (1Z,5E)-4-Hydroxy-6-phenylhexa-1,5-dienyl acetate (30f). 
Trans-cinnamaldehyde  17f (0.32 mmol, 42 mg, 1.0 equiv) and 
3-bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 equiv) were subjected to the 
reaction conditions described in GP1. Flash column chromatography with 1:3 
EtOAc/hexanes provided a colorless oil of 30f (63 mg, 85%). Rf = 0.14; IR (film, cm-1): 
3467(br), 3055, 2987, 2928, 1747, 1264; 1H NMR (300 MHz, CDCl3) δ 7.43-7.27 (m, 
5H), 7.17 (d, J = 7.5 Hz, 1H), 6.64 (d, J = 16 Hz, 1Η), 6.27 (dd, J = 16, 6.6 Hz, 
1Η), 5.01 (q, J = 7.5 Hz, 1H), 4.42-4.36 (m, 1H), 2.58-2.51 (m, 2H), 2.17 (s, 3H), 2.03 
(s, 1H); 13C NMR (75 MHz, CDCl3) δ 168.1, 136.5, 136.1, 131.4, 130.7, 128.7 (2), 
127.8, 126.5 (2), 109.0, 72.1, 32.6, 20.8; HRMS (ESI) calcd for C14H16O3 [M+Li]+: 
239.1259; found: 239.1216. 
 
 (Z)-4-Hydroxy-5-phenylpent-1-enyl acetate (30g). 2-
Phenylacetaldehyde 17g (0.32 mmol, 38 mg, 1.0 equiv) and 3-
bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 equiv) were subjected to the 
reaction conditions described in GP1. Flash column chromatography with 1:4 
EtOAc/hexanes provided a colorless oil of 30g (52 mg, 75%). Rf = 0.18; IR (film, cm-1): 
OH
OAc
OH
OAc
  
40 
3443 (br), 3028, 2916, 2848, 1752, 1670; 1H NMR (300 MHz, CDCl3) δ 7.34-7.20 (m, 
5H), 7.14 (d, J = 7.5 Hz, 1H), 5.01 (q, J = 7.5 Hz, 1H), 3.98-3.81 (m, 1H), 2.89-2.67 (m, 
2H), 2.42-2.37 (m, 2H), 2.14 (s, 3H), 1.69 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 168.1, 
138.3, 136.1, 129.5, 129.1, 128.7, 126.7, 126.6, 109.6, 72.1, 43.4, 31.9, 20.8; HRMS 
(ESI) calcd for C13H16O3 [M+Li]+: 227.1259; found: 227.1200. 
 
 (Z)-4-Hydroxy-6-phenylhex-1-enyl acetate (30h). 3-
Phenylpropanal 17h (0.32 mmol, 41 mg, 1.0 equiv) and 3-
bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 equiv) were subjected to the 
reaction conditions described in GP1. Flash column chromatography with 1:4 
EtOAc/hexanes provided a colorless oil of 30h (60 mg, 80%). Rf = 0.16; IR (film, cm-1): 
3416 (br), 3064, 3023, 2937, 2863, 1758, 1673; 1H NMR (300 MHz, CDCl3) δ 7.31-7.14 
(m, 5H), 7.14 (d, J = 7.5 Hz, 1H), 4.94 (q, J = 7.5 Hz, 1H), 3.72-3.65 (m, 1H), 2.81-2.66 
(m, 2H), 2.38-2.33 (m, 2H), 2.14 (s, 3H), 1.90-1.76 (m, 2H), 1.63 (s, 1H); 13C NMR (75 
MHz, CDCl3) δ 168.1, 142.0, 136.2, 128.5 (4), 126.0, 109.5, 70.5, 38.5, 32.7, 32.1, 20.8; 
HRMS (ESI) calcd for  C14H18O3 [M+Li]+: 241.1416; found: 241.1327. 
 
 (Z)-4-Cyclohexyl-4-hydroxybut-1-enyl acetate (30i). 
Cyclohexanealdehyde 17i (0.32 mmol, 36 mg, 1.0 equiv) and 3-
bromoprop-1-enyl acetate 29c (115 mg, 0.64 mmol, 2.0 equiv) were subjected to the 
reaction conditions described in GP1. Flash column chromatography with 1:5 
EtOAc/hexanes provided a colorless oil of 30i (65 mg, 96%). Rf = 0.23; IR (film, cm-1): 
OH
OAc
OH
OAc
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3446 (br), 2925, 2854, 1755; 1H NMR (300 MHz, CDCl3) δ 7.12 (d, J = 7.5 Hz, H), 
4.97 (q, J = 7.5 Hz, 1H), 3.41 (bs, 1H), 2.37-2.30 (m, 2H), 2.14 (m, 2H), 2.14 (s, 3H), 
1.92-1.01 (m, 11H); 13C NMR (75 MHz, CDCl3) δ 168.2, 136.0, 110.4, 75.5, 43.1, 29.6, 
29.3, 28.0, 26.5, 26.3, 26.2, 20.9; MS (ESI) 304 [M+H]+; HRMS (ESI) calcd for 
C12H20O3 [M+Li]+ 219.1572; found 219.1556. 
 
(Z)-4-(4-Acetylphenyl)-4-hydroxybut-1-enyl acetate (30j). 
4-Acetylbenzaldehyde 17j (0.32 mmol, 47 mg, 1.0 equiv) 
and 3-bromoprop-1-enyl acetate 29c (77 µL, 0.64 mmol, 2 
equiv) were subjected to the reaction conditions described in GP1. Flash 
chromatography with 1:2 EtOAc/hexanes provided a colorless oil of 30j (55 mg, 70%). 
Rf = 0.21; IR (film, cm-1): 3464 (br), 2960, 2922, 1750, 1675, 1604; 1H NMR (300 MHz, 
CDCl3) δ 7.85 (d, J = 3.5 Hz, 2Η), 7.40 (d, J = 3.5 Hz, 2Η), 7.01 (d, J = 2.9 Hz, 1Η), 
4.85 (q, J = 7.5 Hz, 1H), 4.76 (t, J = 6.1 Hz, 1H), 3.05 (bs, 1H), 2.60-2.55 (m, 2H), 2.52 
(s, 3H), 2.03 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 198.1, 167.8, 149.4, 136.2, 136.0, 
128.4 (2), 125.9 (2), 108.8, 72.8, 34.2, 26.5, 20.6; HRMS (ESI) calcd for C14H16O4 
[M+H]+: 249.1127; found: 249.1090. 
 
(Z)-Methyl4-(4-acetoxy-1-hydroxybut-3-
enyl)benzoate (30k). Methyl 4-formylbenzoate 17k 
(0.32 mmol, 52 mg, 1.0 equiv) and 3-bromoprop-1-enyl 
acetate 29c (77 µL, 0.64 mmol, 2 equiv) were subjected to the reaction conditions 
OH
OAcMe
O
OH
OAcO
O
Me
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described in GP1. Flash chromatography with 1:2 EtOAc/hexanes provided a colorless 
oil of 30k  (60 mg, 71%). Rf = 0.38; IR (film, cm-1): 3496 (br), 2954, 2904, 1755, 1720; 
1H NMR (300 MHz, CDCl3) δ 7.98 (d, J = 4.0 Hz, 2Η), 7.41 (d, J = 4.0 Hz, 2Η), 7.07 (d, 
J = 3.0 Hz, 1Η), 4.88 (q, J = 7.5 Hz, 1H), 4.76 (t, J = 6.1 Hz, 1H), 3.8 (s, 3H), 2.64-2.57 
(m, 2H), 2.54 (s, 1H), 2.08 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 167.9, 167.0, 149.0, 
136.3, 130.0 (2), 129.8, 129.4, 125.8 (2), 108.7, 73.1, 52.2, 34.3, 20.7; HRMS (ESI) 
calcd for C14H16O5 [M+H]+: 265.1076; found: 265.1068. 
 
(Z)-4-(4-Cyanophenyl)-4-hydroxybut-1-enyl acetate (30l). 
4-Formylbenzonitrile 17l (0.32 mmol, 42 mg, 1.0 equiv) and 
3-bromoprop-1-enyl acetate 29c (77 µL, 0.64 mmol, 2 equiv) 
were subjected to the reaction conditions described in GP1. Flash chromatography with 
1:1 EtOAc/hexanes provided a colorless oil of 30l  (55 mg, 75%). Rf = 0.32; IR (film, 
cm-1): 3478 (br), 3101, 3064, 2925, 1752 1673, 1604; 1H NMR (300 MHz, CDCl3) 
δ 7.61 (d, J = 3.9 Hz, 2Η), 7.47 (d, J = 3.9 Hz, 2Η), 7.08 (d, J = 3.4 Hz, 1H), 4.87 (q, J = 
7.1 Hz, 1H), 4.80 (t, J = 6.2 Hz, 1H), 2.60-2.55 (m, 2H), 2.55 (bs , 1H), 2.09 (s, 3H) ; 
13C NMR (75 MHz, CDCl3) δ 167.8, 149.2, 136.5, 132.2 (2), 126.5 (2), 118.8, 111.1, 
108.2, 72.6, 34.3, 20.6; HRMS (ESI) calcd for C13H13NO3 [M+H]+: 232.0974; found: 
232.0808 
 
 
OH
OAc
N
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(Z)-4-(4-(Tert-butyldimethylsilyloxy)phenyl)-4-
hydroxybut-1-enyl acetate (30m). 4-(Tert-
butyldimethylsilyloxy)benzaldehyde 17m (0.32 mmol, 
75 mg, 1.0 equiv) and 3-bromoprop-1-enyl acetate 29c (77 µL, 0.64 mmol, 2 equiv) 
were subjected to the reaction conditions described in GP1. Flash chromatography with 
1:3 EtOAc/hexanes provided a colorless oil of 30m  (107 mg, 99%). Rf = 0.38; IR (film, 
cm-1): 3443 (br), 2954, 2931, 2889, 2863, 1758; 1H NMR (300 MHz, CDCl3) δ 7.21 (d, J 
= 4.6 Hz, 2Η), 7.07 (d, J = 3.2 Hz, 1Η), 6.81 (d, J = 4.6 Hz, 2H), 4.88 (q, J = 7.3 Hz, 
1H), 4.65 (t, J = 6.4 Hz, 1H), 2.69-2.48 (m, 2H), 2.14 (bs , 1H), 2.11 (s, 3H), 0.98 (s, 
9H), 0.19 (s, 6H) ; 13C NMR (75 MHz, CDCl3) δ 168.0, 155.3, 136.6, 135.9, 128.5, 
127.1, 120.0, 119.8, 109.6, 73.3, 34.3, 25.7 (3), 20.8, 18.3, -4.4 (2); HRMS (ESI) calcd 
for C18H28LiO4Si [M+Li]+: 343.1917; found: 343.1716 
 
(Z)-4-(Benzo[d][1,3]dioxol-5-yl)-4-hydroxybut-1-enyl 
acetate (30n). 1,3-Benzodioxole-5-carbaldehyde 17n (0.32 
mmol, 48 mg, 1.0 equiv) and 3-bromoprop-1-enyl acetate 29c 
(77 µL, 0.64 mmol, 2 equiv) were subjected to the reaction conditions described in GP1. 
Flash chromatography with 1:3 EtOAc/hexanes provided a colorless oil of 30n (77 mg, 
96%). Rf = 0.21; IR (film, cm-1): 3467 (br), 2901, 1752, 1670, 1504, 1489; 1H NMR (300 
MHz, CDCl3) δ 7.03 (d, J = 6.3 Hz, 1Η), 6.84 (s, 1Η), 6.75 (d, J = 1.5 Hz, 1H) 6.74(s, 
1H), 5.91 (s, 2H), 4.84 (q, J = 7.4 Hz, 1H), 4.59 (t, J = 6.9 Hz, 1H), 2.64-2.44 (m, 2H), 
2.38 (bs , 1H), 2.09 (s, 3H) ; 13C NMR (75 MHz, CDCl3) δ 168.0, 147.7, 147.0, 138.0, 
OH
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135.8, 119.3, 109.3, 108.0, 106.4, 101.0, 73.4, 34.2, 20.7 ; HRMS (ESI) calcd for 
C13H14LiO5 [M+Li]+: 257.1001; found: 257.0851 
 
 (2S,3R)-3-((S)-2-Hydroxy-2-phenylethyl)oxiran-2-yl acetate 
(33a). VO(acac)2 (5.3 mg, 0.02 mmol, 0.02 equiv), olefin 30a (206 
mg, 1 mmol, 1 equiv), and TBHP (5.5M solution in decane) (0.36 mL, 2  mmol, 2 equiv) 
were subjected to the reaction conditions described in GP2. Flash column 
chromatography with EtOAc/hexanes (1:3) provided a colorless oil of 33a (182 mg, 
82%). Rf = 0.20, dr = 13 : 1 (determined by 1H NMR); IR (film, cm-1): 3449 (br), 3058, 
3034, 2925, 1758; 1H NMR (300 MHz, CDCl3) major diastereoisomer : δ 7.43-7.26 (m, 
5H), 5.50 (d, J = 2.64 Hz, 1H), 4.92 (t, J = 6.1 Hz, 1H), 3.05 (ddd, J = 2.7, 5.2, 7.7 Hz, 
1H,), 2.53 (bs, 1H), 2.22-2.01 (m, 2H), 2.09 (s, 3H); minor diastereoisomer : δ 7.43-7.26 
(m, 5H), 5.55 (d, J = 2.64 Hz, 1H), 4.92 (t, J = 6.1 Hz, 1H), 3.26 (ddd, J = 2.7, 4.4, 7.7 
Hz, 1H), 2.60 (bs, 1H), 2.22-2.01 (m, 2H), 2.09 (s, 3H); 13C NMR (75 MHz, CDCl3) 
major diastereoisomer : δ 170.7, 143.5, 128.7 (2), 128.0, 125.8 (2), 75.1, 72.4, 54.1, 
36.3, 20.9; minor diastereoisomer : δ 170.7, 143.8, 128.6 (2), 127.9, 125.7 (2), 75.8, 
71.6, 53.9, 36.3, 20.9; HRMS (ESI) calcd for C12H14O4 [M+Li]+: 229.1052; found: 
229.1022. A mixture of diastereoisomers was synthesized from 30a with m-CPBA 
following GP4. 
 
(2S,3R)-3-((S)-2-(2-Bromophenyl)-2-hydroxyethyl)oxiran-2-yl 
acetate (33e). VO(acac)2 (5.3 mg, 0.02 mmol, 0.02 equiv), olefin 
OH
OAc
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30e (284 mg, 1 mmol, 1 equiv), and TBHP (5.5M solution in decane) (0.36 mL, 2  
mmol, 2 equiv) were subjected to the reaction conditions described in GP2. Flash 
column chromatography with EtOAc/hexanes (1:3) provided a colorless oil of 30e (194 
mg, 85%). Rf = 0.23, dr = >15:1 (determined by 1H NMR); IR (film, cm-1): 3437 (br), 
3064, 2937, 1744, 1723; 1H NMR (300 MHz, CDCl3) major diastereoisomer : δ 7.61 (d, 
J = 7.91 Hz, 1H), 7.49 (d, J = 7.91 Hz, 1H), 7.33 (t, J = 8.1 Hz, 1H), 7.13 (t, J = 8.12 Hz, 
1H), 5.52 (d, J = 2.4 Hz, 1H), 5.28 (dd, J = 3.83, 8.60 Hz, 1H), 3.24 (ddd, J = 2.52, 6.04, 
6.04 Hz, 1H), 2.97 (bs, 1H), 2.15-1.97 (m, 2H), 2.07 (s, 3H); minor diastereoisomer 
: δ 7.61 (d, J = 7.91 Hz, 1H), 7.49 (d, J = 7.91 Hz, 1H), 7.33 (t, J = 8.1 Hz, 1H), 7.13 (t, 
J = 8.12 Hz, 1H), 5.52 (d, J = 2.4 Hz, 1H), 5.28 (dd, J = 3.83, 8.60 Hz, 1H), 3.24 (ddd, J 
= 2.52, 6.04, 6.04 Hz, 1H), 2.97 (bs, 1H), 2.15-1.97 (m, 2H), 2.05 (s, 3H); 13C NMR (75 
MHz, CDCl3) major diastereoisomer : δ 170.7, 142.6, 132.6, 129.1, 127.9, 127.3, 121.4, 
74.9, 70.9, 54.2, 35.0, 20.9; minor diastereoisomer : δ 170.7, 142.6, 132.2, 129.0, 127.7, 
127.1, 121.4, 75.5, 70.2, 53.5, 34.0, 20.9; HRMS (ESI) calcd for C12H13BrO4 [M+Li]+: 
307.0157; found: 307.0038. A mixture of diastereoisomers was synthesized from 30e 
with m-CPBA following GP4. 
 
 (2S,3R)-3-((S)-2-Cyclohexyl-2-hydroxyethyl)oxiran-2-yl acetate 
(33i). VO(acac)2 (5.3 mg, 0.02 mmol, 0.02 equiv), olefin 30i (212 
mg, 1 mmol, 1 equiv), and TBHP (5.5M solution in decane) (0.36 mL, 2  mmol, 2 equiv) 
were subjected to the reaction conditions described in GP2. Flash column 
chromatography with EtOAc/hexanes (1:5) provided a colorless oil of 33i (194 mg, 
OH
OAc
O
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85%). Rf = 0.21, dr = 15 : 1 (determined by 1H NMR); IR (film, cm-1): 3425 (br), 2925, 
2851, 1741; 1H NMR (300 MHz, CDCl3) major diastereoisomer : δ 5.53 (d, J = 2.60 Hz, 
1H), 3.61 (ddd, J = 3.81, 5.48, 9.19 Hz, 1H), 3.20 (ddd, J = 2.72, 5.71, 6.83 Hz, 1H), 
2.12 (s, 1H), 2.0 (bs, 1H), 1.89-1.65 (m, 7H), 1.44-1.32 (m, 1H), 1.30-1.14 (m, 3H), 
1.11-0.96 (m, 3H); minor diastereoisomer : δ  5.58 (d, J = 2.60 Hz, 1Η), 3.61 (ddd, J = 
3.81, 5.48, 9.19 Hz, 1H), 3.20 (ddd, J = 2.72, 5.71, 6.83 Hz, 1H), 2.12 (s, 1H), 2.0 (bs, 
1H), 1.89-1.65 (m, 7H), 1.44-1.32 (m, 1H), 1.30-1.14 (m, 3H), 1.11-0.96 (m, 3H); 13C 
NMR (75 MHz, CDCl3) major diastereoisomer :δ 170.7, 75.1, 74.3, 55.0, 43.7, 31.3, 
28.8, 28.0, 26.4, 26.1, 26.0, 20.9; minor diastereoisomer : δ 170.7, 76.1, 73.4, 54.6, 43.9, 
31.3, 29.0, 27.8, 26.4, 26.1, 26.0, 20.9; HRMS (ESI) calcd for C12H20O4 [M+Li]+: 
235.1522; found: 235.1461. A mixture of diastereoisomers was synthesized from 30i with 
m-CPBA following GP4.   
 
 (1R,2S)-2-((S)-2-Hydroxy-2-phenylethyl)cyclopropyl acetate 
(34a). Zn(Et) 2 (123 mg, 1 mmol, 2 equiv), CH2I2 (534 mg, 2 mmol, 
4 equiv), TFA (114 mg, 1 mmol, 2 equiv), and olefin 30a (103 mg, 0.5 mmol, 1 equiv) 
were subjected to the reaction condition described in GP3. Flash column 
chromatography with Et2O/hexanes (1:1) provided a colorless oil of  34a (105 mg, 95%). 
Rf = 0.28, dr = 6.6:1 (determined by chiral HPLC); IR (film, cm-1): 3428 (br), 3042, 
3002, 2934, 1732; 1H NMR (300 MHz, CDCl3) major diastereoisomer : δ 7.37-7.24 (m, 
5H), 4.77 (t, J = 6.48 Hz, 1H), 4.09 (ddd, J = 3.39, 6.83, 6.83 Hz, 1H), 2.5 (bs, 1H), 2.04 
(s, 3H), 1.86-1.80 (m, 2H), 1.04-0.85 (m, 2H), 0.45 (ddd, J = 3.43, 6.11, 6.11 Hz, 1H); 
OH
OAc
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minor diastereoisomer : δ 7.37-7.24 (m, 5H), 4.77 (t, J = 6.48 Hz, 1H), 4.09 (ddd, J = 
3.39, 6.83, 6.83 Hz, 1H), 2.5 (bs, 1H), 2.04 (s, 3H), 1.86-1.80 (m, 2H), 1.04-0.85 (m, 
2H), 0.36 (ddd, J = 3.43, 6.11, 6.11 Hz, 1H); 13C NMR (75 MHz, CDCl3) major 
diastereoisomer :δ 172.0, 144.5, 128.4 (2), 127.5, 125.9 (2), 74.4, 52.0, 36.8, 20.8, 13.2, 
10.8; minor diastereoisomer : 172.0, 144.5, 128.4 (2), 126, 125.8 (2), 74.4, 52.5, 37.0, 
20.8, 13.6, 10.7; HRMS (ESI) calcd for C13H16O3 [M+Li]+: 227.1259; found: 227.1292; 
Chiral HPLC: ChiralPAK® AD-H column, isopropanol:hexanes = 5:95, 1.0 mL/min, λ = 
210 nm; major diastereoisomer tR = 18.0 min and 20.4 min, minor diastereoisomer tR = 
17.2 min and 19.1 min. A mixture of diastereoisomers was synthesized from 30a with 
Et2Zn and ICH2Cl  following the GP5. 
 
 (1R,2S)-2-((S)-2-Hydroxy-2-o-tolylethyl)cyclopropyl acetate 
(34d). Zn(Et) 2 (123 mg, 1 mmol, 2 equiv), CH2I2 (534 mg, 2 mmol, 
4 equiv), TFA (114 mg, 1 mmol, 2 equiv), and olefin 30d (110 mg, 0.5 mmol, 1 equiv) 
were subjected to the reaction condition described in the GP3. Flash column 
chromatography with Et2O/hexanes (1:1) provided a colorless oil of 34d (98 mg, 84%). 
Rf = 0.28, dr = 5:1 (determined by HPLC); IR (film, cm-1): 3446 (br), 3073, 3023, 2992, 
1741; 1H NMR (300 MHz, CDCl3) δ 7.49 (dd, J = 7.70, 1.08 Hz, 1H), 7.26-7.09 (m, 
3H), 5.0 (dd, J = 8.10, 4.86 Hz, 1H), 4.10 (ddd, 6.92, 6.92, 3.34 Hz, 1H), 2.47 (bs, 1H), 
2.32 (s, 3H), 2.02 (s, 3H), 1.89-1.68 (m, 2H), 1.08 (ddd, J = 7.27, 7.27, 1.87 Hz, 1H), 
0.92 (ddd, J = 9.38, 9.38, 6.51 Hz, 1H), 0.43 (ddd, J = 6.63, 6.63, 3.34 Hz, 1H); 13C 
NMR (75 MHz, CDCl3) δ 171.9, 142.7, 134.1, 130.2, 127.1, 126.2, 125.2, 70.4, 52.2, 
OH
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35.9, 20.8, 18.9, 13.2, 11.0; HRMS (ESI) calcd for C14H18O3 [M+Li]+: 241.1416; found: 
241.1367; Chiral HPLC: ChiralPAK® AD-H column, isopropanol:hexanes = 2:98, 0.6 
mL/min, λ = 210 nm; major diastereoisomer tR = 34.5 min, minor diastereoisomer tR = 
36.4 min and 42.4 min. A The mixture of diastereoisomers was synthesized from 30d 
with Et2Zn and ICH2Cl following the GP5. 
 
 (1R,2S)-2-((S)-2-(2-Bromophenyl)-2-hydroxyethyl)cyclopropyl 
acetate (34e). Zn(Et)2 (123 mg, 1 mmol, 2 equiv), CH2I2 (534 mg, 2 
mmol, 4 equiv), TFA (114 mg, 1 mmol, 2 equiv), and olefin 30e (142 mg, 0.5 mmol, 1 
equiv) were subjected to the reaction conditions described in GP3. Flash column 
chromatography with Et2O/hexanes (1:1) provided a colorless oil of 34e (119 mg, 80%). 
Rf = 0.3, dr = 3.8:1 (determined by HPLC); IR (film, cm-1): 3446 (br), 3067, 3005, 2919, 
1744; 1H NMR (300 MHz, CDCl3) major diastereoisomer :δ  7.59 (dd, J = 7.8, 1.6 Hz, 
1H), 7.50 (dd, J = 8.06, 1.19 Hz, 1H), 7.33 (ddd, J = 7.52, 7.52, 0.78 Hz, 1H), 7.12 (ddd, 
7.94, 7.94, 1.85 Hz, 1H), 5.17 (app bs, 1H), 4.12 (ddd, J = 6.91, 6.91, 3.45 Hz, 1H), 2.63 
(bs, 1H), 2.04 (s, 3H), 1.87-1.77 (m, 2H), 1.09 (ddd, J = 9.66, 7.07, 2.83 Hz, 1H), 0.92 
(ddd J = 9.66, 9.66, 6.84 Hz, 1H), 0.43 (ddd, J = 6.77, 6.77, 5.31 Hz, 1H); minor 
diastereoisomer : δ  7.59 (dd, J = 7.8, 1.6 Hz, 1H), 7.50 (dd, J = 8.06, 1.19 Hz, 1H), 7.33 
(ddd, J = 7.52, 7.52, 0.78 Hz, 1H), 7.12 (ddd, 7.94, 7.94, 1.85 Hz, 1H), 5.17 (app bs, 
1H), 4.12 (ddd, J = 6.91, 6.91, 3.45 Hz, 1H), 2.63 (bs, 1H), 2.01 (s, 3H), 1.87-1.77 (m, 
2H), 1.09 (ddd, J = 9.66, 7.07, 2.83 Hz, 1H), 0.92 (ddd J = 9.66, 9.66, 6.84 Hz, 1H), 0.43 
(ddd, J = 6.77, 6.77, 5.31 Hz, 1H); 13C NMR (75 MHz, CDCl3) major diastereoisomer 
OH
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: δ 172.1, 143.4, 132.6, 128.9, 127.7, 127.6, 121.8, 72.6, 52.1, 35.4, 21.1, 12.9, 11.1; 
minor diastereoisomer : δ 172.1, 143.4, 132.5, 128.7, 127.7, 127.3, 121.8, 73.0, 52.6, 
35.2, 20.8, 13.4, 10.4; HRMS (ESI) calcd for C13H15BrO3 [M+Li]+: 305.0365; found: 
305.0262. Chiral HPLC: Chiralcel® OJ-H column, isopropanol:hexanes = 4:96, 1.0 
mL/min, λ = 210 nm; major diastereoisomer tR = 21.6 min and 29.2 min, minor 
diastereoisomer tR = 27.2 min and 31.2 min. A mixture of diastereoisomers was 
synthesized from 30e with Et2Zn and ICH2Cl  following GP5.  
 
 (1R,2S)-2-((S)-2-Cyclohexyl-2-hydroxyethyl)cyclopropyl 
acetate (34i). Zn(Et) 2 (123 mg, 1 mmol, 2 equiv), CH2I2 (534 mg, 2 
mmol, 4 equiv), TFA (114 mg, 1 mmol, 2 equiv), and olefin  30i (106 mg, 0.5 mmol, 1 
equiv) were subjected to the reaction condition described in the GP3. Flash column 
chromatography with Et2O/hexanes (1:1) provided a colorless oil of 34i (99 mg, 88%). 
Rf = 0.21, dr = 6 : 1 (determined by 1H NMR); IR (film, cm-1): 3437 (br), 2925, 2851, 
1744; 1H NMR (300 MHz, CDCl3) major diastereoisomer : δ 4.07 (ddd, J = 3.42, 6.87, 
6.87 Hz, 1H), 3.37 (app q, J = 6.54 Hz, 1H), 2.00 (s, 3H), 1.84 (bs, 1H), 1.81-0.86 (m, 
15H), 0.41 (ddd, J = 3.43, 6.66, 6.66 Hz, 1H); minor diastereoisomer : δ 4.07 (ddd, J = 
3.42, 6.87, 6.87 Hz, 1H), 3.37 (app q, J = 6.54 Hz, 1H), 2.00 (s, 3H), 1.84 (bs, 1H), 1.81-
0.86 (m, 15H), 0.33 (ddd, J = 3.43, 6.66, 6.66 Hz, 1H); 13C NMR (75 MHz, CDCl3) 
major diastereoisomer: δ 172.0, 75.9, 52.1, 43.4, 31.8, 29.1, 27.9, 26.5, 26.3, 26.1, 20.8, 
13.4, 10.8; minor diastereoisomer: δ 172.0, 75.9, 52.8, 43.6, 31.5, 29.2, 27.7, 26.5, 26.3, 
26.1, 20.8, 13.8, 10.3 ; HRMS (ESI) calcd for  C13H22O3 [M+Li]+: 233.1729; found: 
OH
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233.1652. A mixture of diastereoisomers was synthesized from 30i with Et2Zn and 
ICH2Cl following GP5. 
 
1.7.7 Hydrolysis Procedure of Homoaldol Equivalent Adduct 30a 
OH
Ph
OAc
O
OHPh
3230a
LiOH
MeOH, THF, H2O, rt
 
 
5-Phenyltetrahydrofuran-2-ol (32). To a solution of (Z)-4-hydroxy-4-
phenylbut-1-enyl acetate 30a (30 mg, 0.14 mmol, 1 equiv) in 
CH3OH/THF/H2O (4 mL, 1.5:1.5:1) was added LiOH (6 mg, 0.14 mmol, 
1 equiv) and the heterogeneous reaction mixture was vigorously stirred at room 
temperature for 10 min. The organic solvent was evaporated under reduced pressure and 
the aqueous layer was extracted with THF. The combined organic layers were dried 
MgSO4 and evaporated under reduced pressure. Purification was accomplished by flash 
column chromatography (EtOAc/hexanes = 1:1) to give the desired product 32 as 
colorless oil (24 mg, 99% yield). Rf = 0.5 (EtOAc/hexanes = 1:1); 1H NMR (300 MHz, 
CDCl3) δ 7.45-7.24 (m, 10H) (mixture of diastereomers), 5.75 (dd, J = 5.1, 2.0 Hz, 1H), 
5.61 (dd, J = 5.1, 2.0 Hz, 1H), 5.25 (t, J = 7.1 Hz, 1H), 5.01 (t, J = 6.1 Hz, 1H), 3.7 (bs, 
1H), 3.6 (bs, 1H), 2.52-1.73 (m, 8H) (mixture of diastereomer); 13C NMR (75 MHz, 
CDCl3) (mixture of diastereomer) δ 142.8, 142.4, 128.4, 127.6, 127.5, 126.5, 125.7, 
99.0, 98.6, 83.0, 79.7, 34.5, 33.1, 32.9, 32.8; HRMS (ESI) calcd for C10H12O2 [M+Li]+ 
171.0997; found 171.0940. 
O
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1.7.8 Reduction Procedure of Homoaldol Equivalent Adduct 30a 
OH
Ph
OAc
NaBH4, NaOH
OH
Ph
OH
30a 31
H2O, rt
 
 
1-Phenylbutane-1,4-diol (31). To a solution of (Z)-4-hydroxy-4-
phenylbut-1-enyl acetate 30a (30 mg, 0.14 mmol, 1 equiv) in 
MeOH (1 mL) was added a solution of NaBH4 (6 mg, 0.16 mmol, 1.1 equiv) in NaOH (1 
M solution) (0.145 mL, 0.14 mmol, 1 equiv) and the resulting mixture was stirred for 2 h 
at room temperature. The organic solvent was evaporated under reduced pressure and the 
aqueous layer was extracted with Et2O. The combined organic layers were dried over 
MgSO4 and evaporated under reduced pressure. Purification was accomplished by flash 
column chromatography eluting with EtOAc/hexanes (1:1). The fractions containing 
product were combined and concentrated under reduced pressure to give the desired 
product 31 as colorless oil (24 mg, 99% yield). Rf = 0.22 (EtOAc/hexanes = 1:1); 1H 
NMR (300 MHz, CDCl3) δ 7.33-7.22 (m, 5H), 4.68 (t, J = 6.17 Hz, 1H), 3.69-3.56 (m, 
2H), 3.25 (bs, 1H), 2.85 (bs, 1H), 1.86-1.79 (m, 2H), 1.69-1.58 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ 144.8, 128.5 (2), 127.5, 125.9 (2), 74.4, 62.8, 36.4, 29.7. 
 
1.7.9 Stereochemical Proofs of Compound 33d and 34c 
Ph
OH
OAc
O
Ph
O
OAc
O
CH3H3C
Ph
OH OH
Ph
OH OHAcCl, NEt3
PPTS
DMP
33b 33c 33d33a
OH
acetone, !CH2Cl2
0 °C to rt
 LiBH4
Et2O
0 °C to rt
OAc
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 (2R,4S)-4-Phenylbutane-1,2,4-triol (33b). To a solution of 
epoxide 33a (68mg, 0.31 mmol, 1 equiv) in 5 mL Et2O was added 
LiBH4 (2 M in THF) (1.02 mmol, 3.3 equiv) over 30 min at 0 °C and then the reaction 
mixture was allowed to warm up to rt (18 °C to 22 °C). After 30 min stirring, the 
reaction mixture was quenched with saturated aqueous NaHCO3 solution at 0 °C. The 
layers were separated and the aqueous layer was extracted with CH2Cl2. The combined 
organic layers were dried over MgSO4, filtered, and concentrated under reduced 
pressure. Purification was accomplished by flash column chromatography eluting with 
EtOAc/hexanes (3:1) to give the desired product 33b as colorless oil (22 mg, 40% yield). 
Rf = 0.14; 1H NMR (300 MHz, CDCl3) δ 7.34-7.26 (m, 5H), 4.91 (dd, J = 9.7, 3.4 Hz, 
1H), 4.39 (bs, 1H), 4.19 (bs, 1H), 3.94 (bs, 1H), 3.57-3.40 (m, 3H), 2.19-1.83 (m, 1H), 
1.73-1.68 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 144.2, 128.6 (2), 127.8, 125.8 (2), 
74.0, 72.2, 66.9, 41.5 
 
 (2R,4S)-2,4-Dihydroxy-4-phenylbutyl acetate (33c). To a 
solution of triol 33b (22 mg, 0.12 mmol, 1 equiv) and Et3N (37 
mg, 0.36 mmol, 3 equiv) in CH2Cl2 (1 mL) was added AcCl (10 mg, 0.127 mmol, 1.05 
equiv) dropwise at 0 °C and then the reaction mixture was allowed warm up to rt (18 °C 
to 22 °C). After 3 h stirring at rt (18 °C to 22 °C), water was added. The layers were 
separated and the organic layer was washed with water and brine. The combined organic 
layers were dried over MgSO4, filtered, and concentrated under reduced pressure. 
Purification was accomplished by flash column chromatography, eluting with 
OH OH
OH
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EtOAc/hexanes (3:1) to give the desired product 33c as colorless oil (16 mg, 60% yield). 
Rf = 0.42; 1H NMR (300 MHz, CDCl3) δ 7.38-7.28 (m, 5H), 4.98 (dd, J = 10.59, 3.68 
Hz, 1H), 4.16-4.13 (m, 1H), 4.11 (dd, J = 11.46, 3.64 Hz, 1H), 4.03 (dd, J = 11.55, 6.74 
Hz, 1H), 3.43 (bs, 1H), 3.14 (bs, 1H), 2.09 (s, 3H), 1.97-1.90 (m, 1H), 1.80 (app dt, J = 
2.94, 2.94, 5.73 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 171.3, 144.0, 128.7 (2), 128.0, 
125.8 (2), 74.7, 70.4, 68.5, 41.6, 21.0; HRMS (ESI) calcd for C12H16O4 [M+Li]+ 
231.1209; found 231.1091. 
 
(4R,6S)-2,2-Dimethyl-6-phenyl-1,3-dioxan-4-yl)methyl 
acetate (33d). To a solution of diol 33c (10 mg, 0.045 mmol, 1 
equiv) and DMP (13.7 mg, 0.18 mmol, 4 equiv) in acetone (0.5 
mL) was added PPTS (0.6 mg, 0.002 mmol, 0.05 equiv) at rt (18 °C to 22 °C). The 
resulting reaction mixture was refluxed for 24 h. The solvent was removed under 
reduced pressure and water was added. The layers were separated and the organic layer 
was washed with water, saturated aqueous NaHCO3 solution, and brine. The organic 
layer was dried over MgSO4, filtered, and concentrated under reduced pressure. 
Purification was accomplished by flash column chromatography eluting with 
EtOAc/hexanes (1:10) to give the desired product 33d as a colorless oil (8 mg, 70% 
yield). Rf = 0.2; IR (film, cm-1): 3064, 3031, 2996, 2964, 2880, 1741, 1H NMR (300 
MHz, CDCl3) δ 7.39-7.28 (m, 5H), 4.94 (dd, J = 11.71, 2.73 Hz, 1H), 4.31-4.22 (m, 1H), 
4.09 (ddd, J = 15.60, 11.58, 4.29 Hz, 1H), 2.09 (s, 3H), 1.74 (app dt, J = 2.74, 2.74, 
12.98 Hz, 1H), 1.58 (s, 3H), 1.53 (s, 3H), 1.36 (dd, J = 52.09, 18.0, 1H); 13C NMR (75 
OAc
OO
CH3H3C
  
54 
MHz, CDCl3) δ 171.1, 142.0, 128.6 (2), 127.8, 126.0 (2), 99.4, 71.1, 67.6, 67.2, 35.4, 
30.2, 21.0, 19.8; HRMS (ESI) calcd for C15H20O4 [M+Li]+ 271.1522; found 171.1385. 
 
Ph
OH
OH
34c34a
O
O
Ph
H3C CH3
Ph
OH
OAc
34b
PPTS
DMP
acetone, 60 °CMeOH/H2O (3:1), rt
LiOH
 
 
 (1R,2R)-2-((S)-2-Hydroxy-2-phenylethyl)cyclopropanol (34b). To a 
solution of (1R,2S)-2-((S)-2-hydroxy-2-phenylethyl)cyclopropyl acetate 
(34a) (74 mg, 0.337 mmol, 1 equiv) in MeOH/H2O (4 mL) was added LiOH (40 mg, 
1.687 mmol, 5 equiv) at 0 °C. The resulting reaction mixture was allowed to warm up to 
rt (18 °C to 22 °C) and stirred for 10 min. The reaction mixture was neutralized with 1N 
HCl and the solvent removed under reduced pressure. The resulting aqueous phase was 
extracted with Et2O. The organic phase was dried over MgSO4, filtered, and 
concentrated under reduced pressure. Purification was accomplished by flash column 
chromatography eluting with Et2O/hexanes (2:1) to give the desired product 34b as 
colorless oil  (60 mg, 99% yield). Rf = 0.28; 1H NMR (300 MHz, CDCl3) δ 7.56-
7.23 (m, 5H), 4.91-4.88 (m, 1H), 3.65 (bs, 1H), 3.50 (bs, 1H), 3.38-3.32 (m, 1H), 2.40-
2.16 (m, 1H), 1.18-1.77 (m, 1H), 0.65-0.58 (m, 1H), 0.52-0.40 (m, 1H), 0.26-0.21 (m, 
1H); 13C NMR (75 MHz, CDCl3) δ 144.0, 128.2 (2), 127.2, 125.8 (2), 73.4, 49.0, 36.1, 
13.5, 13.1; HRMS (ESI) calcd for C11H14O2 [M+Li]+ 185.1154; found 185.1148. 
 
Ph
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(1R,5S,7R)-3,3-Dimethyl-5-phenyl-2,4-dioxabicyclo[5.1.0]octane 
(34c). To a solution of (1R,2R)-2-((S)-2-hydroxy-2-
phenylethyl)cyclopropanol (34b) (60 mg, 0.337 mmol, 1 equiv) in 
acetone (4 mL) was add DMP (103 mg, 1.348 mmol, 4 equiv) and PPTS (4.2 mg, 0.016 
mmol, 0.05 equiv) at rt (18 °C to 22 °C). The resulting mixture was refluxed overnight 
and the solvent was removed under reduced pressure. The resulting aqueous phase was 
extracted with CH2Cl2. The organic phase was dried over MgSO4, filtered, and 
concentrated under reduced pressure. Purification was accomplished by flash column 
chromatography eluting with Et2O/hexanes (1:1) to give the desired product 34c as 
colorless oil (18 mg, 25% yield). Rf = 0.78; 1H NMR (300 MHz, CDCl3) δ 7.36-7.21 (m, 
5Η), 4.82 (dd, J = 9, 4 Hz, 1H), 3.55 -3.40 (m, 1H), 2.27-2.17 (m, 1H), 1.58 (s, 3H), 
1.33 (s, 3H), 0.86-0.84 (m, 1H), 0.49-.048 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 143.7, 
128.3 (2), 127.0, 125.9 (2), 102.6, 69.0, 50.4, 37.5, 25.5, 25.4, 11.7; HRMS (ESI) calcd 
for C14H18O2 [M+Li]+ 225.1467; found 225.1507. 
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CHAPTER II 
INDIUM-CATALYZED CYCLOISOMERIZATION OF ACETYLENIC 
EPOXIDES TO 2,3,5-TRISUBSTITUTED FURANS 
2.1 Introduction and Background of Furan Synthesis  
 Heterocyclic compounds such as furans, thiofurans, and pyrroles, especially in 
drug discovery, have become important targets in the organic community due to not only 
their numerous appearance in natural products42-45 but also their versatile applications in 
organic synthesis such as in pesticide synthesis.46 Furans are some of the most-
synthesized heterocyclic compounds because they are frequently found in partial 
structures of many natural products42 (Figure 2.1).  
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Figure 2.1. Furan-Containing Natural Products. 
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 In 1902 Feist and Benary reported a classic method for generating furans utilizing 
a condensation reaction between α-haloketones and β-dicarbonyl compounds.47 Since 
Feist reported this furan synthesis,47 a large number of synthetic methods toward furan 
synthesis have been reported.  
          Recent work directed toward furan synthesis featured transition metal-catalyzed 
reactions and Lewis acid-mediated syntheses. For example, palladium-catalyzed 
cyclization of acetylenic ketones 35 furnished bicyclic tri-substituted furans 36 as 
reported by Fukuda and co-workers (Scheme 2.1).48 Additionally, platinum-catalyzed 
cyclization of propargylic oxiranes 37 in aqueous media proceeded smoothly to give tri-
substituted furans 38 as reported by Yoshida et al. in 2009 (Scheme 2.1).49 However, 
these transition metal-catalyzed syntheses of furans have suffered from moderate yields 
under both Pd(II)48 and Pt(II) catalyzed reaction conditions.49  
 
Scheme 2.1. Transition Metal-Catalyzed Furan Synthesis 
O
Et
O EtPdCl2(MeCN)2
(5 mol%) 
THF, !, 1 h
75%
Bu
O Bu
PtCl2 (10 mol%) 
dioxane-H2O (2:1) 
100 °C, 10 min
83%
O
35 36
37 38
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The gold-mediated transformation of alkynyl epoxides 39 to furans 40 has been 
disclosed by Hashmi (Scheme 2.2)50 and molybdenum-catalyzed cyclization of 
propagylic oxiranes 41 to furans 42 as reported by McDonald has been well-established 
(Scheme 2.2).51 On the other hand, these Au(III)50 and Mo(V) catalysts51 exhibited 
limited substrate scope for furan synthesis, only providing moderate yields. 
 
Scheme 2.2. Au- and Mo-Catalyzed Furan Synthesis 
O
Me
OH
AuCl3 (5 mol%) 
MeCN, rt, 17 h
80%
O
Me
OH
H
O H
Et3N:Mo(CO)5 
(11 mol%)
Et2O, rt, 18 h
85%
O
39
41
40
42  
 
Lewis acid-mediated syntheses of furans, including use of ZnCl2 for 
cycloisomerization of alkynyl ketones 43 to cyclopropane substituted furans 44 as 
introduced by Sniady,52 and AgOTf-mediated isomerization of alkynyl epoxides 37 to 
furans 38 as disclosed by Blanc (Scheme 2.3),53 have now been reported. These Lewis 
acid-mediated syntheses of furans, however, exhibit poor functional group tolerance. 
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Scheme 2.3. Lewis Acid-Mediated Furan Synthesis 
O
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H
ZnCl2 (10 mol%)
CH2Cl2, rt, 2 h
85%
O
Ph
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(5 mol%)
CH2Cl2-MeOH, rt, 24 h
80%
O
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37 38  
 
 
 
 
 
 
 
 
 
2.2 Specific Aim 
 Although numerous methods for furan synthesis have been previously reported, 
there are some limitations in substrate scope, functional group tolerance, and low 
product yield in many cases.  Thus, a reliable synthetic method toward furans, solving 
issues with current limitations, needs to be developed due to their versatile application in 
pharmaceutical industries. In this context, we desired to develop an efficient 
methodology employing mild and atom-economical reaction conditions affording highly 
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substituted furans which can serve as valuable precursors in alkaloid natural product 
synthesis54,55 and organic synthesis.  
2.3 Synthesis of Acetylenic α,β-Epoxides 
 Acetylenic α,β-epoxides were synthesized using several different methods. For 
example, Sonogashira cross-coupling reactions56 between vinyl halides 45 and alkynes 
46 afforded tetra-substituted enynes 47. Epoxidation of olefin 48 furnished the 
acetylenic α,β-epoxides 49 (Scheme 2.4)57 and a cascade reaction of alkynyl halides 51 
and di-substituted phenones 50 via α-brominated ketone intermediates provided tetra-
substituted oxiranes 52 (Scheme 2.4).58 Furthermore, treatment of α-haloketones 53 and 
acetylides 54e generated the acetylenic α,β-epoxides 55 by nucleophilic ring closure of 
propargylic alcohols (Scheme 2.4).59,60 These known methods for the synthesis of 
acetylenic α,β-epoxides require either the use of expensive reagents56,57 or low product 
yields.60 Therefore we wished to develop a highly cost effective and efficient method 
toward synthesis of acetylenic α,β-epoxides. 
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Scheme 2.4. Synthesis of Acetylenic α,β-epoxides  
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Table 2.1. Epoxides by Treatment of α-Bromo Ketones with Lithium Acetylidesa 
57a, >99%
57b, 89%c
57c, 85%c
57d, 90%c
57e, 70%
57f, 95%
57g, 99%
57h, 96%
R1
Li
+
O
R2
Br
R3 THF 
–78 °C to rt (2 h)
O
HR2
R3
R1
5456 57
O
HPh
Me
Ph
O
HPh
Bn
Ph
O
HPh
i-Pr
Ph
O
Hn-Pr
Et
Ph
O
HPh
Me
EtO2C
O
HPh
Me
TMS
O
HPh
Me
TES
O
HPh
Me
n-Pr
SM productb SM productb
O
Ph
Br
Me
Ph
Li
O
Ph
Br
Bn
Ph
Li
O
Ph
Br
i-Pr
Ph
Li
O
n-Pr
Br
Et
Ph
Li
O
Ph
Br
Me
CO2Et
Li
O
Ph
Br
Me
TMS
Li
O
Ph
Br
Me
TES
Li
O
Ph
Br
Me
n-Pr
Li
54a56a
54a56b
54a56c
54a56d
54b56a
54c56a
54d56a
54e56a
 
a Reactions were performed using α-bromoketones 56 (0.32 mmol) and lithium acetylides 54 (0.35 mmol) 
in 1 mL THF at rt for 2 h and quenched with saturated aqueous NaHCO3. b Isolated yield after column 
chromatography. c Calculated yield accounting for inseparable impurities (See Experimental Procedure for 
spectra and details of purity). 
 
 
This project began with preparation of the acetylenic α,β-epoxides, which could 
undergo cycloisomerization to afford the desired furans. After screening several 
acetylides, which were prepared from ZnCl2 and Mg, we found that the addition of 
lithium acetylides to α-bromoketones proceeded very efficiently to generate tri-
substituted oxiranes (Table 2.1). Upon treatment of 2-bromopropiophenone 56a with 
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lithium phenyl acetylide 54a, the desired product of phenyl acetylenic α,β-epoxide 57a 
was obtained in quantitative yield (Table 2.1).61 When β-substituted ketones 56b and 
56c were subjected to standard reaction conditions (THF, –78 °C to rt, 2 h), furans 57b 
and 57c were also obtained in very high yields (Table 2.1, 89% and 85%, respectively). 
Aliphatic ketone 56d and acetylide 54a also was converted efficiently to the epoxide 57d 
in 90% yield. When an acetylide with electron deficient substituent 54b was employed, a 
lower yield (70%) of epoxide product 57e was observed (Table 2.1). We also observed 
high yield of epoxides 57f and 57g in 95% and 99% yields, respectively, when silyl-
protected acetylides 54c and 54d with 56a were subjected to these reaction conditions 
(Table 2.1).  Additionally, we were interested in use of aliphatic acetylides to α-
bromoketones to access aliphatic acetylenic α,β-epoxides. Accordingly, Aliphatic 
substituted acetylide 54e was treated with 56a, resulted in 96% yield of furan 57h.  
Having now developed this useful transformation of acyclic 2-bromoketones and 
acetylides to acetylenic α,β-epoxides, 2-bromo-1-indanone 58 was treated with 
phenylethynyl lithium 54a using standard reaction conditions. However, it was observed 
that cyclization of a conformationally restricted cyclic α-haloketone failed to provide the 
epoxide. It is clear that the required SN2 replacement of the bromide by the neighboring 
alkoxide could not occur, because nucleophilic attack of the acetylide 54a to 2-bromo-1-
indanone 58 occurred from the less hindered side of the ketone to produce the unreactive 
syn-hydroxybromide 59 (eq 2). 
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HO
Br
Ph
Br
O
(2)
Ph
Li
+
THF 
–78 °C to rt (2 h)
54%
58 54a 59  
 
The stereochemical outcome of the reaction was consistent with Felkin-Anh 
controlled addition of nucleophile to the ketone and followed by SN2 displacement of the 
bromide by alkoxide.62 The stereochemistry of the tri-substituted oxirane was 
determined by NOE analysis (Table 2.2).61  
 
Table 2.2. Key NOE Enhancements in 57a 
O
HB
MeC
Irradiated H Observed H % nOe
B
B
A
C
2.5
C B
4.1
2.1
HA
2.5%
4.1%
 
 
2.4 Cycloisomerization of Oxiranes to Furans 
 Indium is an important element in synthesis and has been employed for many 
organic transformations including Mannich reactions,63allylation of aldehydes,64 and 
aldol reactions (Scheme 2.5).65 Although Indium is a potentially versatile tool in organic 
synthesis, indium-mediated isomerization and rearrangement have only been reported in 
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limited cases, such as in the Beckman rearrangement66 and Ferrier rearrangement 
(Scheme 2.5).67 Thus, due to both its exceptional stability to air and water and 
reasonable cost as a Lewis acid65 indium attracted our attention when searching for new 
transformation of cycloisomerization.  
 
Scheme 2.5. Previously Reported Indium-Mediated Organic Reactions 
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Table 2.3. Initial Cycloisomerization Resultsa 
O
H
Me
Ph
Ph O Me
Ph
Ph
H
catalyst (5 mol%)
toluene
entry time yield (%)btemp (°C)catalyst
57a 60a
Pd2(dba)3, PPh3 100
100
100
100
100
Pt[(C2H5)2S]2Cl2
AuCl3
CuI
InCl3
1
2
3
4
5
6 InCl3 70
48 h
48 h
48 h
48 h
20 min
20 min
16
90
70
21
>99
>99
7 InCl3 50 1 h 95
8 InCl3 40 1 h 10
 
a Reactions were performed using acetylenic α,β-epoxides 
(0.17 mmol) 57a and catalysts (0.0085 mmol) in 1 mL toluene 
and quenched with water. b Isolated yield. 
 
The initial cycloisomerization studies of tri-substituted oxiranes are summarized 
in Table 2.3. Palladium and platinum-catalyzed rearrangement methods are extensively 
utilized in furan synthesis. For example, Palladium68 is known to cycloisomerize 
acetylenic ketones to furans and platinum49 has been employed for cyclization of 
propargylic oxiranes to furans. Pd and Pt are known in other reports for generating 
furans from acetylenic α,β-epoxides via cycloisomerization. However, low yield of 
products was obtained with Pd catalyst and extended reaction time was necessary for Pt 
catalyst (Table 2.3, entries 1 and 2). Gold and copper catalysts were employed for this 
cycloisomerization but they afforded furans in low to moderate yield (Table 2.3, entries 
3 and 4). 
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After extensive screening of transition metals and Lewis acids for 
cycloisomerization of oxiranes to furans, we have developed a highly efficient method 
applicable toward furan synthesis utilizing indium catalysis via cycloisomerization of 
acetylenic α,β-epoxides. Indium catalysts, due to their exceptional stability and 
versatility65 were applied for cycloisomerization of acetylenic α,β-epoxides. Indium 
catalyst InCl3 efficiently transformed oxiranes 57a to furan 60a in quantitative yield in 
only 20 min (Table 2.3, entry 5). Reactions at 70 °C provided the same high yield of 
products (Table 2.3, entry 6). To achieve more mild reaction conditions, reactions were 
conducted at lower temperature (50 °C and 40 °C) but the reaction proceeded more 
slowly (Table 2.3, entries 7 and 8). During our studies toluene was the solvent of choice 
because ethereal solvents such as THF and 1,4-dioxane provide low yield of products 
and decomposition of oxirane.  
With these optimized reaction conditions in hand, we next investigated the scope 
of this reaction under indium catalysis using various epoxides. The results of 
cycloisomerization from the optimized reaction conditions are summarized in Table 2.4. 
When the parent acetylenic α,β-epoxide 57a was employed in the standard reaction 
conditions, the desired product 60a was obtained in quantitative yield after 20 min at 70 
°C (Table 2.4). We were also interested in testing the steric influence on this 
cycloisomerization reaction. Accordingly, the effect of the β-substituents on epoxides 
such as benzyl and isopropyl β-substituted epoxides (Table 2.4, 57b and 57c) was tested 
in the reaction conditions (70 °C, 20 min, toluene). Results of cycloisomerization of the 
β-substituted epoxides indicate that adverse steric interactions appear to be minor in this 
  
68 
reaction, still providing 84% yield of the furan products (Table 2.4, 60b and 60c). 
Treatment of epoxide 57d with InCl3 (5 mol%) led to furan 60d in 95% yield (Table 
2.4).61  
To examine the utility of this method with different substituent patterns on the 
alkyne, the alkynyl epoxide 57e, which contains an electron-withdrawing alkynyl ester, 
was treated with InCl3 (5 mol%) under the reaction conditions, providing 90% yield of 
product 60e (Table 2.4). When trimethylsilyl-protected alkynyl epoxide 57f was 
employed in the reaction conditions, quantitative conversion of the epoxide to the furan 
60f was also observed. However, unexpectedly, it was observed that the structurally 
related triethylsilyl-protected alkynyl epoxide 57g (Table 2.1) decomposed upon 
treatment with InCl3 (5 mol%). Aliphatic alkynyl epoxide 57h, which could be used to 
synthesize 1,5-aliphatic furans that often appear in many natural products,42 also 
efficiently was converted to furan 60h in quantitative yield (Table 2.4). 
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Table 2.4. Scope of the Cycloisomerization Reactiona 
O
HR2
R3
R1
InCl3 (5 mol%)
toluene, 70 °C
O
R1 R3
R2H
57 60
60a, >99%
60b, 84%c
60c, 84%c
60d, 95%
60e, 90%c
60f, >99%
60h, >99%
O
Ph Me
PhH
O
Ph Bn
PhH
O
Ph i-Pr
PhH
O
Ph Et
n-PrH
O
EtO2C Me
PhH
O
TMS Me
PhH
O
n-Pr Me
PhH
57a
57b
57c
57d
O
HPh
Me
Ph
O
HPh
Bn
Ph
O
HPh
i-Pr
Ph
O
Hn-Pr
Et
Ph
57e
57f
57h
O
HPh
Me
EtO2C
O
HPh
Me
TMS
O
HPh
Me
n-Pr
SM productb
 
a Reactions were performed using acetylenic α,β-epoxides 57 (0.17 mmol) 
and InCl3 (0.0085 mmol) in 1 mL toluene at 70 °C for 20 min then 
quenched with water. b Isolated yield after column chromatography. 
cCalculated yield accounting for inseparable impurities (See Experimental 
Procedure for spectra and details of purity). 
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On the basis of these experimental results, a plausible mechanistic cycle for 
cycloisomerization of the acetylenic α,β-epoxide to furans is described in Scheme 2.6. 
First, indium complex is coordinated with the epoxide 57a. Consequently, the indium 
epoxide complex undergoes ring-opening to generate zwitterion 61 which can participate 
in an apparent 1,3-hydride shift69,70 and generate intermediate benzylic cation/enolate 62, 
forming nucleophilic C–O bond, regenerating InCl3, and affording the observed furan 
product 60a.61 
 
 
 
Scheme 2.6. Proposed Mechanistic Cycle for Formation of Furan  
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2.5 Cascade Reactions to Generate Furans 
Cascade reactions,71 allowing formation of multiple bonds in a single  chemical 
operation, are some of the most attractive chemical processes for synthetic organic 
chemists due to atom economy decrease in reaction steps, waste, and time. Accordingly, 
cascade reactions have been utilized in a range of organic synthesis. For example, Diels-
Alder reactions,72 oxirane ring-opening reactions,72,73 and Pauson–Khand reactions74 are 
the several representative reactions that can proceed in cascade process (Scheme 2.7). 
Therefore, we were interested in generating furans from α-halo carbonyl compounds and 
acetylides employing cascade process.  
 
Scheme 2.7. Cascade Reactions in Organic Synthesis 
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Initial studies of furan synthesis from α-bromoketones and acetylides via cascade 
processes started with determination of compatible solvents. When THF was used in the 
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synthesis of furans in this cascade process, furan 60a was obtained in 20% yield (eq 3). 
However, no desired furan 60a was generated employing toluene in the same reaction 
conditions. It was assumed that LiBr, generated from coupling reaction of α-bromo 
propiophenone 56a and phenylethynyl lithium 54a during the reaction, is responsible for 
this phenomenon. To test the effect of LiBr on the formation of furan, LiBr was added to 
the reaction with oxirane (eq 4). Indeed, addition of LiBr to the α,β-acetylenic epoxides 
57a in the standard reaction conditions (InCl3, toluene, 70 °C) resulted in no conversion 
to furan 60a (eq 4). With these preliminary results in hand, the reaction conditions were 
modified. For instance, SiO2, which could induce oxirane ring opening, was added to the 
reaction instead of InCl3 catalyst, but the reaction did not proceed to afford product (eq 
5). In order to prevent the interference of LiBr in furan formation, in which LiBr could 
prevent oxirane ring opening which can be catalyzed by InCl3 and subsequently prohibit 
formation of furan, Et3N was added to the reaction to precipitate out LiBr•Et3N complex 
but the furans still did not obtained (eq 6). 
Base on these results, several acetylenic nucleophiles with various cations such 
as sodium acetylide 54f and potassium acetylide 54g were employed under these 
reaction conditions (eq 7 and 8). However, cation modification of acetylenic 
nucleophiles still did not allow formation of the desired furans. Generation of LiBr from 
α-bromo propiophenone and lithium acetylide in the reaction led to LiBr salts which 
were difficult to remove from the reaction media, hindering the cascade reaction to be 
rendered as a synthetically useful reaction.  
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Scheme 2.8. Cascade Reactions for Furan Synthesis 
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2.6 Conclusion 
 Furans are extremely important target intermediates among heterocyclic 
compounds due to both their numerous appearances in biologically active natural 
products and their versatile applications in organic synthesis. Consequently, while 
remarkable synthetic methods toward furan synthesis have been continuously reported, 
improved methods pertaining to substrate scope and product yield are still needed. In 
this context, we have developed a highly efficient and catalytic cycloisomerization 
reaction that transforms acetylenic α,β-epoxides to 2,3,5-tri-substituted furans under 
InCl3 (5 mol%)catalysis. The acetylenic α,β-epoxides were prepared by coupling α-
bromo ketones and lithium acetylides to generate a propargylic alcohol which 
consequently undergoes nucleophilic ring closure. This reaction sequence allows rapid 
construction of highly valuable, tri-substituted furan derivatives employing mild and 
atom-economical reaction conditions 
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2.7 Experimental Procedure 
2.7.1 General Information 
All reactions were carried out under an argon atmosphere in oven-dried 
glassware and with magnetic stirring bar. Dry THF was purified by passing through 
alumina under argon. All commercially obtained reagents were used as received.  
Purification of reaction products was carried out by flash column 
chromatography using silica gel 60 (230-400 mesh). Analytical thin layer 
chromatography was performed on 1.00 mm glass-backed silica gel 60-F plates. 
Visualization was performed with UV light or KMnO4 stain solution. Concentration in 
vacuo refers to the removal of volatile solvent using a rotary evaporator attached to a dry 
diaphragm pump (10-15 mm Hg) and pumping to a constant weight with an oil pump 
(<300 mTorr). Heating was accomplished using silicone oil bath.  Temperature was 
controlled by a temperature controller.  
1H NMR spectra were recorded on a Varian Inova 300 (at 300 MHz) or a Varian 
Mercury 300 (at 300 MHz) NMR and are recorded relative to Me4Si (δ 0.0 ppm). 1H 
NMR coupling constants (J) are reported in Hertz (Hz) and multiplicities are indicated as 
follows: s (singlet), d (doublet), t (triplet), m (multiplet). Proton-decoupled 13C NMR 
spectra were recorded on Varian Inova 300 (at 75 MHz) or a Varian Mercury 300 (at 75 
MHz) and are reported relative to CDCl3 (δ 77.16 ppm). High-resolution mass spectra 
(HRMS) were obtained at TAMU. Infrared spectra were recorded on a Bruker Tensor 27 
spectrometer as a thin film on NaCl plates.  
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2.7.2 General Procedure 1 (GP1) of Synthesis of Acetylenic α,β-epoxides 
R1
Li
+
O
R2
Br
R3 THF 
–78 °C to rt
O
HR2
R3
R1
5456 57  
 
To 2 dram vial was added α-haloketones 56 (0.32 mmol, 1 equiv) and THF (1.0 
mL). The vial was cooled to –78 °C and lithium acetylenides 54 (0.35 mmol, 1.1 equiv) 
was added prepared from acetylene (1.0 equiv) and n-BuLi (1.01 equiv) in THF at –78 
°C. After complete addition of lithium acetylenides 1, the reaction mixture was warmed 
up to rt (18 °C to 22 °C) and stirred for 2 h. The reaction mixture was quenched with 
saturated aqueous NaHCO3 solution (1.5 mL). The layers were separated and the 
aqueous layer was extracted with Et2O. The combined organic layers were washed with 
brine, dried over MgSO4, filtered, and concentrated under reduced pressure. Purification 
was accomplished by flash column chromatography to afford alkynyl oxirane 57. 
 
2.7.3 General Procedure 2 (GP2) of Cycloisomerization 
O
HR2
R3
R1
InCl3 (5 mol %)
toluene, 70 °C
O
R1 R3
R2H
57 60  
 
    A 2 dram vial was charged with InCl3 (0.0085 mmol, 0.05 equiv) in the dry box. 
To the vial was added a solution of oxiranes 57 (0.17 mmol, 1.0 equiv) in THF (1 mL). 
The vial was then placed in a 70 °C oil bath for 20 min. Then cooled to rt (18 °C to 22 
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°C) and quenched with water. The layers were separated and the aqueous layer was 
extracted with Et2O. The combined organic layers were washed with brine, dried over 
MgSO4, filtered, and concentrated under reduced pressure. Purification was 
accomplished by flash column chromatography to afford furan 60. 
 
 (2S,3R)-3-Methyl-2-phenyl-2-(phenylethynyl)oxirane (57a). 
(Phenylethynyl)lithium 54a (0.35 mmol, 38 mg, 1.1 equiv) and halide 
56a (0.32 mmol, 68 mg, 1.0 equiv) were subjected to the reaction conditions described 
in GP1. Flash column chromatography on SiO2 eluting with hexanes:CH2Cl2(1:1) 
provided a colorless oil 57a (75 mg, quantitative yield). Rf = 0.6 (hexanes:CH2Cl2=1:1); 
IR (film, cm-1): 2229, 1317, 938, 867; 1H NMR (300 MHz, CDCl3) δ 7.59-7.57 (m, 2H), 
7.51-7.49 (m, 2H), 7.48-7.41 (m, 2H), 7.39-7.33 (m, 4H), 3.74 (q, J = 5.5 Hz, 1H), 1.14 
(d, J = 5.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 135.7, 132.1 (2), 128.7, 128.3, 128.1 
(2), 128.0 (2), 127.1 (2), 122.2, 88.92, 82.9, 63.5, 56.2, 13.4; HRMS (ESI) calcd for 
C17H15O [M+H]+: 235.1123; found: 235.1131. 
 
 (2S,3R)-3-Benzyl-2-phenyl-2-(phenylethynyl)oxirane (57b). 
(Phenylethynyl)lithium 54a (0.35 mmol, 38 mg, 1.1 equiv) and 
halide 56b (0.32 mmol, 92 mg, 1.0 equiv) were subjected to the reaction conditions 
described in GP1. Flash column chromatography on SiO2 eluting with 
hexanes:CH2Cl2(1:1) provided a colorless oil 57b (96 mg, 99%, 89% pure by 1H and 13C 
NMR). Rf = 0.83 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 2226, 1317, 938, 879; 1H NMR 
O
HPh
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(300 MHz, CDCl3) δ 7.71-7.67 (m, 2H), 7.55-7.26 (m, 11H), 7.26-7.13 (m, 2H), 3.88 (t, 
J = 6.3 Hz, 1H), 2.79 (dd, J = 14.8, 6.1 Hz, 1H), 2.63 (dd, J = 14.8, 6.4 Hz, 1H); 13C 
NMR (75 MHz, CDCl3) δ 136.7, 135.5, 132.0 (2), 128.9 (2), 128.8 (2), 128.7 (2), 128.3 
(3), 128.2, 127.2 (2), 126.7, 122.1, 88.6, 83.2, 67.5, 56.5, 34.0; HRMS (MALDI) calcd 
for C23H18O [M+H]+: 311.1436; found: 311.1442. 
 
 (2S,3R)-3-Isopropyl-2-phenyl-2-(phenylethynyl)oxirane (57c). 
(Phenylethynyl)lithium 54a (0.35 mmol, 38 mg, 1.1 equiv) and 
halide 56c (0.32 mmol, 77 mg, 1.0 equiv) were subjected to the reaction conditions 
described in GP1. Flash column chromatography on SiO2 eluting with 
hexanes:CH2Cl2(1:1) provided a colorless oil 57c (80 mg, 95%, 85% pure by 1H and 13C 
NMR). Rf = 0.76 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 2226, 1320, 891, 755; 1H NMR 
(300 MHz, CDCl3) δ 7.60-7.56 (m, 2H), 7.52-7.47 (m, 2H), 7.45-7.31 (m, 6H), 3.27 (d, J 
= 8.3 Hz, 1H), 1.13 (app s, 4H), 0.82 (d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
135.9, 132.0 (2), 128.7, 128.3 (2), 128.1 (2), 128.0, 126.9 (2), 122.3, 89.1, 82.9, 73.0, 
56.7, 26.8, 19.6, 17.9; HRMS (MALDI) calcd for C19H18O [M+H]+: 263.1436; found: 
263.1428. 
 
 (2S,3R)-3-Ethyl-2-(phenylethynyl)-2-propyloxirane (57d). 
(Phenylethynyl)lithium 54a (0.35 mmol, 38 mg, 1.1 equiv) and 
halide 56d (0.32 mmol, 62 mg, 1.0 equiv) were subjected to the 
reaction conditions described in GP1. Flash column chromatography on SiO2 eluting 
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with hexanes:CH2Cl2(1:1) provided a colorless oil 57d (68 mg, >99%, 90% pure by 1H 
and 13C NMR). Rf = 0.61 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 2226, 1302, 909, 752; 
1H NMR (300 MHz, CDCl3) δ 7.47-7.45 (m, 2H), 7.35-7.32 (m, 3H), 3.24 (t, J = 6.58 
Hz, 1H), 1.47-1.62 (m, 6H), 1.15-1.01 (m, 6H); 13C NMR (75 MHz, CDCl3) d 131.9 (2), 
128.6, 128.2 (2), 122.4, 89.1, 82.6, 66.5, 55.3, 33.7, 21.5, 19.2, 14.1, 10.5; HRMS (ESI) 
calcd for C15H18O [M+H]+: 215.1436; found: 215.1442. 
 
Ethyl 3-((2S,3R)-3-methyl-2-phenyloxiran-2-yl)propiolate 
(57e). (3-Ethoxy-3-oxoprop-1-yn-1-yl)lithium 54b (0.35 mmol, 36 
mg, 1.1 equiv) and halide 56a (0.32 mmol, 68 mg, 1.0 equiv) were subjected to the 
reaction conditions described in GP1. Flash column chromatography on SiO2 eluting 
with hexanes:CH2Cl2(2:1) provided a colorless oil 57e (52 mg, 70%). Rf = 0.64 
(hexanes:CH2Cl2=2:1);  IR (film, cm-1): 2235, 1708, 1220, 953, 870; 1H NMR (300 
MHz, CDCl3) δ 7.45-7.33 (m, 5H), 4.22 (q, J = 7.2 Hz, 2H), 3.64 (q, J = 5.4 Hz, 1H), 
1.28 (t, J = 6.9 Hz, 3H), 1.06 (d, J = 5.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 152.9, 
133.3, 128.5, 128.3 (2), 126.9 (2), 85.9, 74.1, 63.0, 62.2, 54.9, 13.9, 13.0; HRMS (ESI) 
calcd for C14H14O3 [M+H]+: 231.1021; found: 231.1013. 
 
Trimethyl(((2S,3R)-3-methyl-2-phenyloxiran-2-yl)ethynyl)silane 
(57f). ((Trimethylsilyl)ethynyl) lithium 54c (0.35 mmol, 36 mg, 1.1 
equiv) and halide 56a (0.32 mmol, 68 mg, 1.0 equiv) were subjected to the reaction 
conditions described in GP1. Flash column chromatography on SiO2 eluting with 
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hexanes:CH2Cl2(1:1) provided a colorless oil 57f (70 mg, 95%). Rf = 0.75 
(hexanes:CH2Cl2=1:1); IR (film, cm-1): 2173, 1249, 938, 844; 1H NMR (300 MHz, 
CDCl3) δ 7.52-7.34 (m, 5H), 3.62 (q, J = 5.4 Hz, 1H), 1.07 (d, J = 5.4 Hz, 3H), 0.23 (s, 
9H); 13C NMR (75 MHz, CDCl3) δ 135.3, 128.0 (2), 127.9, 127.1 (2), 104.8, 88.1, 63.3, 
55.9, 13.2, -0.12 (3); HRMS (ESI) calcd for C14H18OSi [M+H]+: 231.1205; found: 
231.1213. 
 
Triethyl(((2S,3R)-3-methyl-2-phenyloxiran-2-yl)ethynyl)silane 
(57g). ((Triethylsilyl)ethynyl) lithium 54d (0.35 mmol, 51 mg, 1.1 
equiv) and halide 56a (0.32 mmol, 68 mg, 1.0 equiv) were subjected to the reaction 
conditions described in GP1. Flash column chromatography on SiO2 eluting with 
hexanes:CH2Cl2(1:1) provided a colorless oil 57g (86 mg, 99%). Rf = 0.70 
(hexanes:CH2Cl2=1:1); IR (film, cm-1): 2170, 1240, 938, 864; 1H NMR (300 MHz, 
CDCl3) δ 7.52-7.33 (m, 5H), 3.62 (q, J = 5.4 Hz, 1H), 1.08 (d, J = 5.8 Hz, 3H), 1.03 (t, J 
= 8.3 Hz, 9H), 0.65 (q, J = 7.8 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 135.4, 128.0, 
127.9 (2), 127.1 (2), 106.1, 85.8, 63.5, 56.0, 13.1, 7.5 (3), 4.3 (3); HRMS (ESI) calcd for 
C17H24OSi [M+H]+: 273.1675; found: 273.1662. 
 
 (2S,3R)-3-Methyl-2-(pent-1-yn-1-yl)-2-phenyloxirane (57h). 
Pent-1-yn-1-yllithium 54e (0.35 mmol, 26 mg, 1.1 equiv) and 
halide 56a (0.32 mmol, 68 mg, 1.0 equiv) were subjected to the reaction conditions 
described in GP1. Flash column chromatography on SiO2 eluting with 
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hexanes:CH2Cl2(1:1) provided a colorless oil 57h (61 mg, 96%). Rf = 0.60 
(hexanes:CH2Cl2=1:1); IR (film, cm-1): 2238, 1448, 867, 752; 1H NMR (300 MHz, 
CDCl3) δ 7.51-7.29 (m, 5H), 3.57 (q, J = 5.4 Hz, 1H), 2.24 (t, J = 7.1 Hz, 2H), 1.64-1.52 
(m, 2H), 1.07 (d, J = 5.4 Hz, 3H), 1.01 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
136.2, 127.9 (2), 127.8, 127.0 (2), 83.9, 80.1, 63.1, 56.1, 21.9, 20.8, 13.6, 13.3; HRMS 
(ESI) calcd for C14H16O [M+H]+: 201.1279; found: 201.1282. 
 
 (1R,2S)-2-Bromo-1-(phenylethynyl)-2,3-dihydro-1H-inden-1-ol 
(59). (Phenylethynyl)lithium 54a (0.35 mmol, 38 mg, 1.1 equiv) 
and 2-bromo-indanone 58 (0.32 mmol, 68 mg, 1.0 equiv) were subjected to the reaction 
conditions described in GP1 for 40 h to afford a colorless oil 59 (54 mg, 54%). Rf = 0.33 
(hexanes:Et2O=5:1); IR (film, cm-1): 3521, 3052, 2228, 1338, 922, 869; 1H NMR (300 
MHz, CDCl3) δ 7.77-7.73 (m, 1H), 7.52-7.44 (m, 2H), 7.42-7.29 (m, 6H), 4.84 (t, J = 7.3 
Hz, 1H), 3.54-3.39 (m, 2H), 3.08 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 142.1, 140.2, 
132.0 (2), 129.9, 128.9, 128.4 (2), 127.9, 124.8, 124.6, 122.0, 88.0, 85.4, 76.1, 60.3, 
39.7; HRMS (MALDI) calcd for C17H13BrO [M+Na]+: 335.0048; found: 335.0037. 
 
 2-Methyl-3,5-diphenylfuran (60a). Oxirane 57a (0.17 mmol, 40 mg 
1.0 equiv) and InCl3 (0.0085 mmol, 1.9 mg, 0.05 equiv) were subjected 
to the reaction conditions described in GP2 to afford colorless oil 60a (40 mg, >99%). Rf 
= 0.83 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 3061, 1599, 1495, 1448, 1018; 1H NMR 
(300 MHz, CDCl3) δ 7.76-7.73 (m, 2H), 7.53-7.42 (m, 6H), 7.38-7.27 (m, 2H), 6.85 (s, 
O
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1H), 2.58 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 151.6, 147.6, 134.1, 130.8, 128.7 (2), 
128.6 (2), 127.5 (2), 127.0, 126.5, 123.4 (2), 123.0, 106.4, 13.2 (4); HRMS (ESI) calcd 
for C17H14O [M+Na]+: 257.0942; found: 257.0949. 
 
2-Benzyl-3,5-diphenylfuran (60b). Oxirane 57b (0.17 mmol, 53 mg 
1.0 equiv) and InCl3 (0.0085 mmol, 1.9 mg, 0.05 equiv) were 
subjected to the reaction conditions described in GP2 to afford colorless oil 60b (53 mg, 
99%, 84% pure by 1H and 13C NMR). Rf = 0.56 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 
3064, 1599, 1495, 1448; 1H NMR (300 MHz, CDCl3) δ 7.78-7.73 (m, 2H), 7.52-7.27 (m, 
13H), 6.89 (s, 1H), 4.27 (s, 2H); 13C NMR (75 MHz, CDCl3) δ 152.5, 149.0, 138.6, 
133.8, 130.8, 128.8 (2), 128.7 (2), 128.6 (2), 128.4, 127.8 (2), 127.3 (2), 126.9, 126.5, 
125.7, 123.7 (2), 106.7, 33.0; HRMS (MALDI) calcd for C23H18O [M+H]+: 311.1436; 
found: 311.1422. 
 
2-Isopropyl-3,5-diphenylfuran (60c). Oxirane 57c (0.17 mmol, 53 
mg 1.0 equiv) and InCl3 (0.0085 mmol, 1.9 mg, 0.05 equiv) were 
subjected to the reaction conditions described in GP2 to afford colorless oil 60c (45 mg, 
99%, 84% pure by 1H and 13C NMR). Rf = 0.72 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 
3058, 1593, 1495; 1H NMR (300 MHz, CDCl3) δ 7.79-7.72 (m, 2H), 7.51-7.27 (m, 8H), 
6.79 (s, 1H), 3.39-3.29 (m, 1H), 1.43 (d, J = 7.0 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 
156.0, 151.4, 134.4, 131.1, 128.7 (2), 128.6 (2), 128.1 (2), 127.1, 126.6, 126.0, 123.5 (2), 
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106.7, 26.7, 23.7, 21.9; HRMS (MALDI) calcd for C19H18O [M+H]+: 263.1436; found: 
263.1448. 
 
2-Ethyl-5-phenyl-3-propylfuran (60d). Oxirane 57d (0.17 mmol, 36 
mg 1.0 equiv) and InCl3 (0.0085 mmol, 1.9 mg, 0.05 equiv) were 
subjected to the reaction conditions described in GP2. Flash column 
chromatography on SiO2 eluting with hexanes:CH2Cl2(20:1) provided colorless oil 60d 
(35 mg, 95%). Rf = 0.85 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 3061, 1599, 1486, 1456, 
1024; 1H NMR (300 MHz, CDCl3) δ 7.67-7.65 (m, 2H), 7.41-7.21 (m, 3H), 6.52 (s, 1H), 
2.70 (q, J = 7.94 Hz, 2H), 2.39 (t, J = 7.58 Hz, 2H), 1.68-1.56 (m, 2H), 1.31 (t, J = 7.72 
Hz, 3H), 1.00 (t, J = 7.42 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 152.6, 151.0, 131.4, 
128.6 (2), 126.6, 123.3 (2), 120.5, 107.3, 26.9, 23.9, 19.6, 13.9, 13.5; HRMS (MALDI) 
calcd for C15H18O [M+H]+: 215.1436; found: 215.1444. 
 
Ethyl 5-methyl-4-phenylfuran-2-carboxylate (60e). Oxirane 57e 
(0.17 mmol, 40 mg 1.0 equiv) and InCl3 (0.0085 mmol, 1.9 mg, 0.05 
equiv) were subjected to the reaction conditions described in GP2 to afford colorless oil 
60e (40 mg, 99%, 90% pure by 1H and 13C NMR). Rf = 0.15 (hexanes:CH2Cl2=1:1); IR 
(film, cm-1): 3061, 1720, 1619, 1187; 1H NMR (300 MHz, CDCl3) δ 7.43-7.38 (m, 5H), 
6.26 (s, 1H), 4.31 (q, J = 7.0 Hz, 2H), 2.51 (s, 3H), 1.36 (t, J = 7.45 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) δ 163.4, 130.0, 129.3 (2), 128.8, 128.6 (2), 114.1, 92.9, 61.8, 28.8, 
24.4, 14.3; HRMS (ESI) calcd for C14H14O3: 231.1021; found: 231.1010. 
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Trimethyl(5-methyl-4-phenylfuran-2-yl)silane (60f). Oxirane 57f 
(0.17 mmol, 39 mg 1.0 equiv) and InCl3 (0.0085 mmol, 1.9 mg, 0.05 
equiv) were subjected to the reaction conditions described in GP2 to afford colorless oil 
60f (39 mg, >99%). Rf = 0.64 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 3061, 2176, 1909, 
1249, 850; 1H NMR (300 MHz, CDCl3) δ 7.48-7.34 (m, 5H), 4.60 (s, 1H), 2.24 (s, 3H), 
0.26 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 202.7, 134.6, 128.9 (2), 128.0, 127.9 (2), 
101.3, 92.5, 53.7, 25.9, 0.0 (3); HRMS (ESI) calcd for C14H18OSi [M+Na]+: 253.1025; 
found: 253.1014. 
 
2-Methyl-3-phenyl-5-propylfuran (60h). Oxirane 57h (0.17 
mmol, 34 mg 1.0 equiv) and InCl3 (0.0085 mmol, 1.9 mg, 0.05 
equiv) were subjected to the reaction conditions described in GP2 to afford colorless oil 
60h (34 mg, >99%). Rf = 0.88 (hexanes:CH2Cl2=1:1); IR (film, cm-1): 3061, 1581, 1495, 
1448; 1H NMR (300 MHz, CDCl3) δ 7.48-7.26 (m, 5H), 6.18 (s, 1H), 2.62 (t, J = 7.24 
Hz, 2H), 2.47 (s, 3H), 1.81-1.69 (m, 2H), 1.06 (t, J = 7.50 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 154.2, 145.8, 134.7, 128.6 (2), 127.4 (2), 126.1, 121.2, 106.3, 30.1, 21.5, 13.9, 
13.1; HRMS (ESI) calcd for C14H16O [M+H]+: 201.1279; found: 201.1289. 
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2.7.4 Key NOE Enhancements in 57a, 57e, and 57f  
O
HB
MeC
Irradiated H Observed H % nOe
B
B
A
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CHAPTER III 
CONCLUSION: PALLADIUM-CATALYZED ALKYNYLATION OF 
SECONDARY α-BROMO CARBONYL COMPOUNDS BY STILLE COUPLING 
REACTIONS 
3.1 Introduction and Background of Cross-Coupling Reaction 
 Cross-coupling reactions, specifically utilizing transition metals and Lewis acids, 
are indispensable synthetic methods for generating C−C and C−N bonds.75-77 The 
organometallic nucleophiles of cross-coupling reactions have been extended to a wide 
range of metals including organolithiums,78 organozincs,79 organostannanes,80 and 
organozirconiums.81 As a result, transition metal catalyzed cross-coupling reactions with 
a variety of metal reagents have been extensively studied. Numerous examples of 
transition metal-catalyzed cross-coupling reactions of α-halo carbonyl compounds with 
aryl metals,82 alkenyl metals,81 and alkyl metals83,84 have been successfully reported, but 
the alkynylation of α-halo carbonyl compounds still remains a difficult task. Few cases 
of cross-coupling reactions mediated by transition metals and Lewis acids generating α-
alkynyl carbonyl compounds have been reported (Scheme 3.1).85,86 Furthermore, there is 
currently only one report of transition metal-catalyzed cross-coupling reactions between 
α-halo carbonyl compounds and alkynyl metals generating α-alkynyl carbonyl 
compounds.85 The alkynyl carbonyl compounds have been utilized in a variety of 
applications to organic synthesis as well as natural product synthesis.87,88 
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Scheme 3.1. Alkynylation of α-Bromo Carbonyl Compounds  
Br
MeO
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 Recent works using cross-coupling reactions for α-functionalization of α-bromo 
carbonyl compounds have featured transition metal-catalyzed reactions. For example, 
nickel-catalyzed cross-coupling reactions between secondary α-halo carbonyl 
compounds and aryl zinc reagents furnish α-aryl ketones,89 nickel-mediated 
intermolecular cross-coupling reactions of α-bromo ketones with alkenylzirconium 
reagent proceed successfully to give β,γ-unsaturated ketones,81 and nickel-catalyzed 
cross-coupling reactions of α-bromo carbonyl compounds with zinc metal reagents 
provide α-alkyl carbonyl compounds (Scheme 3.2).84 
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Scheme 3.2. Functionalization of α-Bromo Carbonyl Compounds by Cross-Coupling 
Reactions  
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However, alkynylation of α-halo carbonyl compounds with alkynyl metal 
reagents via cross-coupling reaction have been recognized as a challenging reaction. 
Indeed, there is only one precedent of transition metal-catalyzed alkynylation of primary 
α-bromo carbonyl compounds with alkyl metal reagents (Scheme 3.1).85 
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3.2 Specific Aim 
 α-alkynyl carbonyl compounds are highly valuable precursors for many chemical 
compounds ranging from pharmaceuticals to agricultural applications.46 Since there are 
no straightforward synthetic methods toward secondary α-alkynyl carbonyl compounds,  
we desired to develop an efficient methodology for cross-coupling reactions producing 
secondary α-alkynyl carbonyl compounds that could be further studied in both 
asymmetric alkynylation and cycloisomerization to furans (Scheme 3.3).  
 
Scheme 3.3. Current Synthetic Routes for α-Functionalization of α-Bromo Carbonyl 
Compounds 
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3.3 Pd-Catalyzed Cross-Coupling Reactions of α-Bromo Carbonyl Compounds and 
Tin Acetylides 
 This project began with screening of alkynyl metal reagents that could undergo 
cross-coupling reaction with α-halo carbonyl compounds, generating α-alkynyl carbonyl 
compounds. After extensive screening of metal reagents ranging from 
tris(phenylethynyl)indium to tributyl(phenylethynyl)stannane, the desired cross-coupling 
products were generated in 60 % yield by treatment of α-halo carbonyl compounds and 
tributyl(phenylethynyl)stannane (Table 3.1, entry 10). Having discovered the optimal 
metal reagents for the reaction, further optimization of reaction conditions was 
conducted as described in Table 3.1. 
Initial cross-coupling reaction studies of α-bromo esters 63a and 
tributyl(phenylethynyl)stannane 64 are summarized in Table 3.1. When a bulky ligand 
such as Xantphos was used with palladium catalyst PdCl2(MeCN)2, methyl 2-
bromopropanoate 63a, and tributyl(phenylethynyl)stannane 64 under standard reaction 
conditions (110 °C, 20 min, toluene), the cross-coupling product of α-alkynyl carbonyl 
compound 65a was generated in 31% yield (Table 3.1, entry 1) along with the 
homocoupled diyne byproduct.85 
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Table 3.1. Initial Screening Results of Cross-Coupling Reactionsa 
entry yield (%)btemp (°C)catalyst
110
110
110
110
110
PdCl2(MeCN)2
PdCl2(MeCN)2
PdCl2(MeCN)2
PdCl2(MeCN)2
1
2
3
5
6
7 PdCl2(PhCN)2 110
31
55
43
50
51
56
8 NiCl2•Glyme 110 0
9 Pd(PPh3)4 110 50
Me
MeO
O
Br
catalyst (5 mol%)
ligand (12 mol%)
solvent, 20 min
Me
MeO
O
Ph
+
63a 64 65a
Sn(Bu)3
Ph
ligand
Xantphos
JohnPhos
DavePhos
PyBoxi-Pr
BINAP
XPhos
PdCl2(MeCN)2
solvent
toluene
toluene
toluene
toluene
toluene
toluene
toluene
toluene
110PdCl2(MeCN)210
11 PdCl2(MeCN)2 70
60
37
12 PdCl2(MeCN)2 80 20
c
XPhos
XPhos
XPhos
toluene
THF
MeCN
110PdCl2(MeCHN)24 42TangPhos toluene
 
a Reactions were performed using catalyst (5 mol %, 0.016 mmol), ligand 
(12 mol %, 0.038 mmol), α-bromocarbonyl compound 63a (0.32 mmol, 1 
equiv), and tributyl(phenylethynyl)stannane 64 (0.64 mmol, 2 equiv) in 
solvent (1.0 mL) at 110 °C for 20 min and then quenched with KF solution 
(1 M, 1.0 mL). b Isolated yield after column chromatography. c 12 h reaction 
time. 
 
 
   
Other phosphine ligands (Table 3.2) including JohnPhos, DavePhos, TangPhos, 
and BINAP with Pd(II) catalyst PdCl2(MeCN)2 were subjected to standard reaction 
conditions (110 °C, 20 min, toluene) affording cross-coupling products in 55%, 43%, 
42%, and 51% yield respectively (Table 3.1, entries 2, 3, 4, and 6). However, the highest 
yield of cross-coupling products was obtained from combination of PdCl2(MeCN)2 and 
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the Xphos ligand, providing 60% yield (Table 3.1, entry 10). Unfortunately, no desired 
cross-coupling product was generated when NiCl•Glyme, which has previously been 
successful for other cross-coupling reactions for α-halo carbonyl compounds,81,84,89 was 
employed in standard reaction conditions (Table 3.1, entry 8). Pd(PPh3)4 also provided 
the cross-coupling product in 50% yield (Table 3.1, entry 9).  
 
Table 3.2. Ligands of Cross-Coupling Reactions 
Xantphos JohnPhos DavePhos
PyBoxi-Pr BINAP XPhos
TangPhos
O
Me Me
P P
PhPhPhPh
P
t-Bu
t-Bu
P
Cy
CyN
Me
Me
P P
t-Bu t-Bu
H
H
N
N
OO
N
i-Pr i-Pr
P(Ph)2
P(Ph)2
P
Cy
Cy
i-Pr
i-Pr
i-Pr
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Table 3.3. Scope of the Cross-Coupling Reactionsa 
SM productb SM productb
O
MeO
Br
Me
O
BnO
Br
Me
O
s-BuO
Br
Me
O
MeO
Br
i-Pr
O
MeO
Br
t-Bu
O
(Et)2N
Br
Me
O
N
Br
Me
O
N
Br
Me
63g
63h
63i
R1
R2
O
Br
PdCl2(MeCN)2 (5 mol%)
XPhos (10 mol%)
toluene, 110 °C
R1
R2
O
Ph
+
63 64
65
Sn(Bu)3
Ph
O
BnO
Br
i-Pr
O
(Et)2N
Br
i-Pr
63j
O
N
Br
i-Pr
63k
Me
MeO
O
Ph
65a, 60%
65b, 60%
65c, 55%
65d, 55%
Me
BnO
O
Ph
Me
s-BuO
O
Ph
i-Pr
MeO
O
Ph
65e, 51%c
i-Pr
BnO
O
Ph
65f, 36%
t-Bu
MeO
O
Ph
63a
63b
63c
63d
63e
63f
65g, 42%
65h, 35%
Me
(Et)2N
O
Ph
Me
N
O
Ph
65i, 55%
Me
N
O
Ph
O
65j, 40%
i-Pr
(Et)2N
O
Ph
65k, 50%
i-Pr
N
O
Ph
O
O
O
 
a Reactions were performed using PdCl2(MeCN)2 (5 mol %, 0.016 mmol), XPhos (12 mol %, 0.038 
mmol), α-bromocarbonyl compound 63 (0.32 mmol, 1 equiv), and tributyl(phenylethynyl)stannane 64 
(0.64 mmol, 2 equiv) in toluene (1.0 mL) at 110 °C for 20 min and then quenched with KF solution (1 M, 
1.0 mL). b Isolated yield after column chromatography. c Calculated yield accounting for inseparable 
impurities (See Experimental Procedure for spectra and details of purity). 
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With these optimized reaction conditions in hand, we explored the scope of this 
reaction with various α-bromo esters and amides and the results of the cross-coupling 
reactions are summarized in Table 3.3. The parent methyl 2-bromopropanoate 63a and 
tributyl(phenylethynyl)stannane 64 underwent clean reaction to provide the desired 
coupling product 65a in 60% yield after 20 min at 110 °C (Table 3.3). The reactions 
with α-bromo benzyl ester 63b and sec-butyl ester 63c also proceed to afford the desired 
cross-coupling products in 60% and 55% respectively (Table 3.3). To test the effect of 
the nature of the β-substituents on α-halo carbonyl compounds, the carbonyl compounds 
with iso-propyl 63e and tetra-butyl 63f groups (Table 3.3) were tested under standard 
reaction conditions. The bulky β-substituent such as iso-propyl and tetra-butyl groups on 
electrophiles decreased the product yields to 5l% (65e) and 36% (65f) respectively 
(Table 3.3). A plausible reason for lower product yields with the electrophile 63e and 
63f could be a result of adverse competition of steric interaction between carbo-
palladation species 66 and oxo-palladation species 67. For example, in the oxidative 
addition step, the electrophile 63f with the bulky tetra-butyl substituent does not favor 
formation of carbo-palladation intermediate 66 due to steric interaction between tetra-
butyl substituent and palladium, but instead prefers to form oxo-palladation intermediate 
67 (eq 9). 
OMe
O
PdBr
OMe
O
PdBr
66 67
(9)
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The α-bromo amides and tributyl(phenylethynyl)stannane 64  also could be 
transformed to α-alkynyl amide compounds via this intermolecular cross-coupling 
reaction. Likewise, 2-bromo-N,N-diethylpropanamide 63g and 
tributyl(phenylethynyl)stannane 64 led to cross-coupling product 65g in 42% yield. It 
was also observed that electron rich α-bromo amides provide higher yields of coupling 
product. For example, 2-bromo-1-morpholinopropan-1-one 63i and 2-bromo-3-methyl-
1-morpholinobutan-1-one 63k with tributyl(phenylethynyl)stannane 64 under standard 
reaction conditions (110 °C, 20 min, toluene) generated the cross-coupling products 65i 
and 65k in 55% and 50% yield respectively (Table 3.2) (compared to Table 3.2, 65g 
(42% yield) 65j (40% yield)). Treatment of 63k with tributyl(phenylethynyl)stannane 64 
using standard reaction conditions resulted in formation of crystals. We have now 
confirmed the structure of compound 65k by single-crystal X-ray analysis (Figure 3.1). 
 
 
 
Figure 3.1. Single-Crystal X-ray Structure of Compound 65k. 
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During these studies we have demonstrated a successful intermolecular cross-
coupling reaction with secondary α-bromo esters and amides with 
tributyl(phenylethynyl)stannane reagents. In addition, we have explored the limitation of 
this method using α-bromo aryl ketones as electrophiles and alkynyl metals as 
nucleophiles for cross-coupling reaction. For example, 2-bromopropiophenone 63l was 
treated with tributyl(phenylethynyl)stannane 64 and tris(phenylethynyl)indium under 
PdCl2(MeCN)2 catalyst and Xphos ligand but these studies failed to afford the desired 
cross-coupling products 65l (path A). It is assumed that the major species from the 
oxidative addition step could be the oxo-palladium intermediate 67a as opposed to the 
carbo-palladium intermediated 66a due to both the electron withdrawing phenyl group 
on the carbonyl group and steric interactions. The intermediate 67a undergoes 
transmetallation with 64 to generate 64a which undergoes a second transmetallation with 
64 to form the homocoupled diyne product 64b in path B (Scheme 3.4).  
 
Scheme 3.4. Attempted Cross-Coupling Reaction of 2-Bromopropiophenone 63l 
Me
Ph
O
PdBr
Me
Ph
O
BrPd
66a67a
O
Ph
Me
Br
Sn(Bu)3
Ph
+
O
Ph
MePdCl2(MeCN)2
XPhos
toluene, 110 °C
63l 64 65l
PdBr
Ph
(Bu)3Sn Ph
transmetallation
Ph Ph
homocoupled diyne
Ph
path Apath B
64a
64b
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Additionally, it is noteworthy that when activated α-bromo cyclohexenone was treated 
with tributyl(phenylethynyl)stannane under standard reaction conditions, no desired 
product was formed. 
Based on the experimental results, a proposed mechanistic cycle for the 
intermolecular cross-coupling reaction is shown in Scheme 3.5. The electrohphile 63a 
undergoes oxidative addition to Pd(0) to form carbo-palladium intermediate 66aa which 
then undergoes transmetallation with tributyl(phenylethynyl)stannane 64 to form the 
intermediate 68. The intermediate 68 is converted to the desired cross-coupling product 
65a after reductive elimination.    
 
Scheme 3.5. Proposed Mechanistic Cycle of Intermolecular Cross-Coupling Reaction 
Pd(0)
transmetallation
63a65a
68 66aa
Me
OMe
O
Ph
Me
OMe
O
Br
Me
OMe
O
PdBr
Me
OMe
O
PdBr
(Bu)3Sn Ph
Me
OMe
O
Pd
Ph
64
67aa
oxidative additionreductive elimination
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3.4 Conclusion 
 Cross-coupling reactions employing transition metals and Lewis acids are 
powerful synthetic tools for the construction of C–C and C–N bonds. Subsequently, a 
number of cross-coupling reactions between α-bromo ketones and metal nucleophiles 
such as aryl metals, alkenyl metals, and alkyl metals have been developed yet cross-
coupling reactions between α-bromo ketones and alkynyl metals have been reported in a 
limited study.  Our studies toward cross-coupling reactions have focused on generation 
of secondary α-alkynyl carbonyl compounds. The first approach to secondary α-alkynyl 
carbonyl compounds was developed under palladium-catalyzed cross-coupling reaction 
conditions. The secondary α-alkynyl carbonyl compounds was prepared from secondary 
α-bromo esters and amides with tributyl(phenylethynyl)stannane using PdCl2(MeCN)2 
catalyst and Xphos ligand. This reaction sequence allows rapid access to valuable, 
secondary α-alkynyl carbonyl derivatives which themselves serve as versatile functional 
groups. 
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3.5 Experimental Procedure 
3.5.1 General Information 
All reactions were carried out under an argon atmosphere in oven-dried 
glassware and with magnetic stirring bar. Dry THF was purified by passing through 
alumina under argon. All commercially obtained reagents were used as received.  
Purification of reaction products was carried out by flash column 
chromatography using silica gel 60 (230-400 mesh). Analytical thin layer 
chromatography was performed on 1.00 mm glass-backed silica gel 60-F plates. 
Visualization was performed with UV light or KMnO4 stain solution. Concentration in 
vacuo refers to the removal of volatile solvent using a rotary evaporator attached to a dry 
diaphragm pump (10-15 mm Hg) and pumping to a constant weight with an oil pump 
(<300 mTorr). Heating was accomplished using silicone oil bath.  Temperature was 
controlled by a temperature controller.  
1H NMR spectra were recorded on a Varian Inova 300 (at 300 MHz) or a Varian 
Mercury 300 (at 300 MHz) NMR and are recorded relative to Me4Si (δ 0.0 ppm). 1H 
NMR coupling constants (J) are reported in Hertz (Hz) and multiplicities are indicated as 
follows: s (singlet), d (doublet), t (triplet), m (multiplet). Proton-decoupled 13C NMR 
spectra were recorded on Varian Inova 300 (at 75 MHz) or a Varian Mercury 300 (at 75 
MHz) and are reported relative to CDCl3 (δ 77.16 ppm). High-resolution mass spectra 
(HRMS) were obtained at TAMU. Infrared spectra were recorded on a Bruker Tensor 27 
spectrometer as a thin film on NaCl plates.  
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3.5.2 General Procedure 1 (GP1) of Cross-Coupling Reaction 
R1
R2
O
Br
PdCl2(MeCN)2 (5 mol%)
XPhos (10 mol%)
toluene, 110 °C
R1
R2
O
Ph
+
63 64
65
Sn(Bu)3
Ph
 
 
To 2 dram vial was added PdCl2(MeCN)2 (5 mol %, 0.016 mmol), XPhos (12 
mol %, 0.038 mmol), and toluene (1.0 mL), followed by α-bromocarbonyl compound 63 
(0.32 mmol, 1 equiv) (Table 3.4) and tributyl(phenylethynyl)stannane 64 (0.64 mmol, 2 
equiv). The reaction mixture was heated at 110 °C for 20 min. The reaction mixture was 
cooled down to rt and was quenched with KF solution (1M, 1.0 mL). The reaction 
mixture was passed through a Celite® plug, the layers were separated, and the aqueous 
layer was extracted with Et2O. The combined organic layers were washed with brine, 
dried over MgSO4, filtered, and concentrated under reduced pressure. Purification was 
accomplished by flash column chromatography to afford alkynyl carbonyl compound 65.     
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Table 3.4. Reference of Known Compounds 63 
O
MeO
Br
Me
O
BnO
Br
Me
O
s-BuO
Br
Me
O
MeO
Br
i-Pr
O
MeO
Br
t-Bu
O
(Et)2N
Br
Me
O
N
Br
Me
O
N
Br
Me
63gb
63hb
63ib
O
BnO
Br
i-Pr
O
(Et)2N
Br
i-Pr
63ja
O
N
Br
i-Pr
63ka
63aa
63bb
63cb
63db
63eb
63fb
O
O
 
a commercially available compounds: 63a, 63j, 63k 
b known compounds: 63b,90 63c,91 63d,92 63e,93 63f,91 63g,94 63h,95 63i96 
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Methyl 2-methyl-4-phenylbut-3-ynoate (65a). α-Bromocarbonyl 
compound 63aa (0.32 mmol, 54 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) were 
subjected to the reaction conditions described in GP1 to afford pale yellow oil 65a (36 
mg, 60% yield). Rf = 0.3 (hexanes:Et2O=20:1); IR (film, cm-1): 1744, 1199, 758; 1H 
NMR (300 MHz, CDCl3) δ 7.44-7.42 (m, 2H), 7.31-7.29 (m, 3H), 3.78 (s, 3H), 3.65 (q, 
J = 7.1 Hz, 1H), 1.54 (d, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 171.8, 131.7 
(2), 128.4 (3), 122.9, 86.9, 82.6, 52.6, 32.7, 18.1; HRMS (ESI) calcd for C12H12O2 
[M+H]+: 189.0916; found: 189.0918. 
 
Benzyl 2-methyl-4-phenylbut-3-ynoate (65b). α-Bromocarbonyl 
compound 63b (0.32 mmol, 78 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) were 
subjected to the reaction conditions described in GP1 to afford pale yellow oil 65b (51 
mg, 60% yield). Rf = 0.26 (hexanes:Et2O=20:1); IR (film, cm-1): 1744, 1489, 1175, 758, 
693; 1H NMR (300 MHz, CDCl3) δ 7.47-7.29 (m, 10H), 5.26 (s, 2H), 3.73 (q, J = 7.4 
Hz, 1H), 1.60 (d, J = 7.0, 3H); 13C NMR (75 MHz, CDCl3) δ 171.2, 135.7, 131.7 (2), 
128.6 (2), 128.4 (2), 128.3 (2), 128.2, 128.0, 123.0, 86.9, 82.8, 67.0, 33.0, 18.0; HRMS 
(ESI) calcd for C18H16O2 [M+H]+: 265.1229; found: 265.1222. 
 
 
Me
MeO
O
Ph
Me
BnO
O
Ph
  
103 
Sec-butyl 2-methyl-4-phenylbut-3-ynoate (65c). α-
Bromocarbonyl compound 63c (0.32 mmol, 67 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 
equiv) were subjected to the reaction conditions described in GP1 to afford pale yellow 
oil 3c (41 mg, 56% yield). Rf = 0.4 (hexanes:Et2O=20:1); IR (film, cm-1): 1735, 1190, 
864, 755, 690; 1H NMR (300 MHz, CDCl3) δ 7.47-7.43 (m, 2H), 7.34-7.29 (m, 3H), 
5.00-4.89 (m, 1H), 3.69 (q, J = 7.3 Hz, 1H), 1.72-1.69 (m, 2H), 1.57-1.53 (m, 3H), 1.29 
(d, J = 6.5 Hz, 3H), 1.01-0.94 (m, 3H); 13C NMR (75 MHz, CDCl3) (mixture of 
diastereoisomer) δ 171.1, 171.0, 131.7, 128.2, 128.0, 123.1, 87.4, 87.3, 82.5, 82.4, 73.4, 
33.3, 33.1, 28.8, 28.7, 19.4, 19.3, 18.2, 17.9, 9.7, 9.6; HRMS (ESI) calcd for C15H18O 
[M+H]+: 231.1385; found: 231.1389. 
 
Methyl 2-isopropyl-4-phenylbut-3-ynoate (65d). α-Bromocarbonyl 
compound 63d (0.32 mmol, 62 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) were 
subjected to the reaction conditions described in GP1 to afford pale yellow oil 65d (38 
mg, 55% yield). Rf = 0.3 (hexanes:Et2O=20:1); IR (film, cm-1): 1744, 1492, 1018, 752, 
690; 1H NMR (300 MHz, CDCl3) δ 7.47-7.41 (m, 2H), 7.31-7.25 (m, 3H), 3.76 (s, 3H), 
3.41(d, J = 6.5 Hz, 1H), 2.33-2.26 (m, 1H), 1.09 (dd, J = 5.3, 6.6 Hz, 6H); 13C NMR (75 
MHz, CDCl3) δ 171.2, 131.7 (2), 128.1 (3), 123.1, 84.5 (2), 52.3, 46.0, 31.2, 20.8, 19.2; 
HRMS (ESI) calcd for C14H16O2 [M+H]+: 217.1229; found: 217.1234. 
 
Me
O
O
Ph
Me
Me
i-Pr
MeO
O
Ph
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Benzyl 2-isopropyl-4-phenylbut-3-ynoate (65e). α-Bromocarbonyl 
compound 63e (0.32 mmol, 87 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) were 
subjected to the reaction conditions described in GP1 to afford pale yellow oil 65e (56 
mg, 60%, 85% pure by 1H and 13C NMR). Rf = 0.23 (hexanes:Et2O=20:1);  IR (film, cm-
1): 1741, 1486, 1166, 755, 693; 1H NMR (300 MHz, CDCl3) δ 7.49-7.29 (m, 10H), 5.14 
(s, 2H), 3.48 (d, J = 6.3 Hz, 2H), 2.40-2.30 (m, 1H), 1.11 (t, J =6.6 Hz, 6H); 13C NMR 
(75 MHz, CDCl3) δ 170.5, 135.7, 131.7 (2), 128.5, 128.2, 128.2, 128.1, 128.0 (3), 123.2, 
84.7, 84.6 (2), 66.9, 46.2, 31.3, 20.9, 19.2; HRMS (ESI) calcd for C20H20O2 [M+H]+: 
293.1542; found: 293.1535. 
 
Methyl 2-(tert-butyl)-4-phenylbut-3-ynoate (65f). α-Bromocarbonyl 
compound 63f (0.32 mmol, 67 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) were 
subjected to the reaction conditions described in GP1 to afford pale yellow oil 65f (26 
mg, 36% yield). Rf = 0.32 (hexanes:Et2O=20:1); IR (film, cm-1): 1735, 1146, 755, 687; 
1H NMR (300 MHz, CDCl3) δ 7.46-7.42 (m, 2H), 7.30-7.28 (m, 3H), 3.75 (s, 3H), 3.37 
(s, 1H), 1.14 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 170.6, 131.7 (2), 128.1 (3), 123.2, 
85.2, 84.4, 52.0, 50.1, 35.0, 27.7 (3); EI MS m/z calcd for C15H18O2 : 230.0; found: 
230.0. 
 
 
i-Pr
BnO
O
Ph
t-Bu
MeO
O
Ph
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N,N-Diethyl-2-methyl-4-phenylbut-3-ynamide (65g). α-
Bromocarbonyl compound 63g (0.32 mmol, 67 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) were 
subjected to the reaction conditions described in GP1 to afford pale yellow oil 65g (31 
mg, 42% yield). Rf = 0.22 (hexanes:EtOAc=4:1); IR (film, cm-1): 1646, 1024, 758, 690; 
1H NMR (300 MHz, CDCl3) δ 7.43-7.40 (m, 2H), 7.32-7.29 (m, 3H), 3.72 (q, J = 6.0 
Hz, 1H), 3.67-3.38 (m, 4H), 1.52 (d, J = 7.2 Hz, 3H), 1.28 (t, J = 6.6 Hz, 3H), 1.17 (t, J 
= 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 169.1, 131.8 (2), 128.3 (2), 128.1, 123.5, 
88.5, 82.5, 42.1, 40.6, 30.3, 17.9, 14.4, 12.9; HRMS (ESI) calcd for C15H19NO [M+H]+: 
230.1545; found: 230.1551. 
 
2-Methyl-4-phenyl-1-(piperidin-1-yl)but-3-yn-1-one (65h). α-
Bromocarbonyl compound 63h (0.32 mmol, 70 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) 
were subjected to the reaction conditions described in GP1 to afford pale yellow oil 65h 
(27 mg, 35% yield). Rf = 0.23 (hexanes:EtOAc=4:1); IR (film, cm-1): 1652, 1436, 1003, 
758, 687; 1H NMR (300 MHz, CDCl3) δ 7.42-7.40 (m, 2Η), 7.32-7.30 (m, 3H), 3.81-
3.73 (m, 2H), 3.71 (q, J = 6.7, 1H), 3.55-3.31 (m, 2H) 1.73-1.56 (m, 6H), 1.52 (d, J = 7.5 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 168.3, 131.8 (2), 128.5 (2), 128.1, 123.4, 88.3, 
82.9, 47.2, 43.7, 30.5, 26.3, 25.8, 25.2, 17.8; EI MS m/z calcd for C16H19NO: 241.0; 
found: 241.0. 
Me
(Et)2N
O
Ph
Me
N
O
Ph
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2-Methyl-1-morpholino-4-phenylbut-3-yn-1-one (65i). α-
Bromocarbonyl compound 63i (0.32 mmol, 71 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) 
were subjected to the reaction conditions described in GP1 to afford pale yellow oil 65i 
(43 mg, 55% yield). Rf = 0.4 (hexanes:EtOAc=1:1); IR (film, cm-1): 1649, 1027, 758, 
690; 1H NMR (300 MHz, CDCl3) δ 7.41-7.39 (m, 2H), 7.33-7.31 (m, 3H), 3.89-3.50 (m, 
8H), 3.67 (q, J = 6.9, 1H), 1.53 (d, J = 7.6, 3H); 13C NMR (75 MHz, CDCl3) δ 168.7, 
131.8 (2), 128.4 (3), 122.9, 87.6, 83.3, 66.9, 66.6, 46.6, 42.8, 30.3, 17.3; HRMS (ESI) 
calcd for C15H17NO2 [M+H]+: 244.1338; found: 244.1332.  
 
N,N-Diethyl-2-isopropyl-4-phenylbut-3-ynamide (65j). α-
Bromocarbonyl compound 63j (0.32 mmol, 76 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) 
were subjected to the reaction conditions described in GP1 to afford pale yellow oil 65j 
(33 mg, 40% yield). Rf = 0.32 (hexanes:EtOAc=4:1); IR (film, cm-1): 1652, 1030, 755, 
690; 1H NMR (300 MHz, CDCl3) δ 7.45-7.42 (m, 2H), 7.32-7.30 (m, 3H), 3.65-3.39 (m, 
4H), 3.31 (d, J = 9.0 Hz, 1H), 2.43-2.33 (m, 1H), 1.29 (t, J = 7.3 Hz, 3H), 1.18 (t, J = 7.3 
Hz, 3H), 1.01 (d, J = 6.9 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 169.1, 131.8 (2), 128.2 
(2),  128.0, 123.5, 87.0, 83.7, 43.8, 42.3, 40.8, 31.0, 21.3, 20.6, 14.8, 13.0; HRMS (ESI) 
calcd for C17H23NO: 258.1858; found: 258.1863.  
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2-Isopropyl-1-morpholino-4-phenylbut-3-yn-1-one (65k). α-
Bromocarbonyl compound 63k (0.32 mmol, 80 mg, 1.0 equiv) and 
tributyl(phenylethynyl)stannane 64 (0.64 mmol, 250 mg, 2.0 equiv) 
were subjected to the reaction conditions described in GP1 to afford pale yellow solid 
65k (43 mg, 50% yield). Rf = 0.5 (hexanes:EtOAc=1:1); IR (film, cm-1): 1649, 1430, 
971, 758, 690; 1H NMR (300 MHz, CDCl3) δ 7.41-7.37 (m, 2H), 7.31-7.26 (m, 3H), 
3.85-3.50 (m, 8H), 3.31 (d, J = 8.2 Hz, 1H), 2.37-2.25 (m, 1H), 1.19 (d, J = 7.1 Hz, 3H), 
1.03 (d, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 168.3, 131.7 (2), 128.4 (3), 
123.1, 86.0, 85.0, 67.2, 66.9, 47.2, 44.2, 43.0, 30.6, 21.7, 20.6; HRMS (ESI) calcd for 
C17H21NO2 [M+H]+: 272.1651; found: 272.1656.  
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Table 1.  Crystal data and structure refinement for compound 65k. 
Identification code  brcb190m 
Empirical formula  C17 H21 N O2 
Formula weight  271.35 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 5.324(8) Å α= 89.195(19)°. 
 b = 10.365(15) Å β= 84.673(18)°. 
 c = 14.32(2) Å γ = 76.599(17)°. 
Volume 765.3(19) Å3 
Z 2 
Density (calculated) 1.178 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 292 
Crystal size 0.60 x 0.46 x 0.38 mm3 
Theta range for data collection 1.43 to 27.47°. 
Index ranges -6<=h<=6, -13<=k<=13, -18<=l<=18 
Reflections collected 7615 
Independent reflections 3402 [R(int) = 0.0287] 
Completeness to theta = 27.47° 97.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9715 and 0.9555 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3402 / 30 / 194 
Goodness-of-fit on F2 1.052 
Final R indices [I>2sigma(I)] R1 = 0.0422, wR2 = 0.1122 
R indices (all data) R1 = 0.0520, wR2 = 0.1182 
Largest diff. peak and hole 0.251 and -0.257 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for compound 65k.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
C(1) 4222(2) 8030(1) -30(1) 29(1) 
C(2) 1800(2) 7901(1) -471(1) 31(1) 
C(3) 1049(3) 6288(1) 627(1) 35(1) 
C(4) 3449(2) 6358(1) 1106(1) 29(1) 
C(5) 4273(2) 8517(1) 1641(1) 28(1) 
C(6) 3815(3) 8038(1) 2679(1) 23(1) 
C(7) 3181(3) 9236(1) 3361(1) 26(1) 
C(8) 3359(3) 8790(2) 4381(1) 35(1) 
C(9) 448(3) 10065(2) 3230(1) 33(1) 
C(6A) 4658(12) 8398(9) 2650(5) 23(1) 
C(7A) 1965(12) 8482(7) 3183(4) 26(1) 
C(8A) 2123(18) 8471(9) 4244(4) 35(1) 
C(9A) 75(15) 9740(8) 2877(7) 33(1) 
C(10) 6181(2) 7021(1) 2870(1) 28(1) 
C(11) 7976(2) 6115(1) 3003(1) 26(1) 
C(12) 10120(2) 5007(1) 3135(1) 24(1) 
C(13) 10684(2) 3913(1) 2520(1) 29(1) 
C(14) 12804(3) 2865(1) 2631(1) 35(1) 
C(15) 14351(3) 2895(1) 3351(1) 43(1) 
C(16) 13805(3) 3967(1) 3966(1) 45(1) 
C(17) 11705(2) 5023(1) 3861(1) 32(1) 
N(1) 3970(2) 7679(1) 966(1) 27(1) 
O(1) 1345(2) 6596(1) -350(1) 34(1) 
O(2) 4828(2) 9585(1) 1456(1) 39(1) 
________________________________________________________________________________ 
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Table 3.   Bond lengths [Å] and angles [°] for compound 65k. 
_____________________________________________________  
C(1)-N(1)  1.470(2) 
C(1)-C(2)  1.520(2) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-O(1)  1.434(2) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-O(1)  1.434(2) 
C(3)-C(4)  1.522(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-N(1)  1.466(2) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-O(2)  1.230(2) 
C(5)-N(1)  1.353(2) 
C(5)-C(6A)  1.478(8) 
C(5)-C(6)  1.575(3) 
C(6)-C(10)  1.487(2) 
C(6)-C(7)  1.546(2) 
C(6)-H(6A)  1.0000 
C(7)-C(8)  1.530(3) 
C(7)-C(9)  1.535(2) 
C(7)-H(7A)  1.0000 
C(8)-H(8A)  0.9800 
C(8)-H(8B)  0.9800 
C(8)-H(8C)  0.9800 
C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 
C(9)-H(9C)  0.9800 
C(6A)-C(10)  1.513(8) 
C(6A)-C(7A)  1.545(5) 
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C(6A)-H(6AA)  1.0000 
C(7A)-C(8A)  1.529(5) 
C(7A)-C(9A)  1.537(5) 
C(7A)-H(7AA)  1.0000 
C(8A)-H(8AA)  0.9800 
C(8A)-H(8AB)  0.9800 
C(8A)-H(8AC)  0.9800 
C(9A)-H(9AA)  0.9800 
C(9A)-H(9AB)  0.9800 
C(9A)-H(9AC)  0.9800 
C(10)-C(11)  1.202(2) 
C(11)-C(12)  1.444(2) 
C(12)-C(17)  1.401(2) 
C(12)-C(13)  1.404(2) 
C(13)-C(14)  1.393(2) 
C(13)-H(13A)  0.9500 
C(14)-C(15)  1.384(2) 
C(14)-H(14A)  0.9500 
C(15)-C(16)  1.386(3) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.389(2) 
C(16)-H(16A)  0.9500 
C(17)-H(17A)  0.9500 
 
N(1)-C(1)-C(2) 109.04(11) 
N(1)-C(1)-H(1A) 109.9 
C(2)-C(1)-H(1A) 109.9 
N(1)-C(1)-H(1B) 109.9 
C(2)-C(1)-H(1B) 109.9 
H(1A)-C(1)-H(1B) 108.3 
O(1)-C(2)-C(1) 111.53(10) 
O(1)-C(2)-H(2A) 109.3 
C(1)-C(2)-H(2A) 109.3 
O(1)-C(2)-H(2B) 109.3 
  
188 
C(1)-C(2)-H(2B) 109.3 
H(2A)-C(2)-H(2B) 108.0 
O(1)-C(3)-C(4) 111.31(11) 
O(1)-C(3)-H(3A) 109.4 
C(4)-C(3)-H(3A) 109.4 
O(1)-C(3)-H(3B) 109.4 
C(4)-C(3)-H(3B) 109.4 
H(3A)-C(3)-H(3B) 108.0 
N(1)-C(4)-C(3) 109.19(10) 
N(1)-C(4)-H(4A) 109.8 
C(3)-C(4)-H(4A) 109.8 
N(1)-C(4)-H(4B) 109.8 
C(3)-C(4)-H(4B) 109.8 
H(4A)-C(4)-H(4B) 108.3 
O(2)-C(5)-N(1) 122.30(13) 
O(2)-C(5)-C(6A) 101.3(4) 
N(1)-C(5)-C(6A) 135.0(4) 
O(2)-C(5)-C(6) 122.45(11) 
N(1)-C(5)-C(6) 115.24(14) 
C(6A)-C(5)-C(6) 24.1(3) 
C(10)-C(6)-C(7) 113.72(12) 
C(10)-C(6)-C(5) 106.91(11) 
C(7)-C(6)-C(5) 110.09(14) 
C(10)-C(6)-H(6A) 108.7 
C(7)-C(6)-H(6A) 108.7 
C(5)-C(6)-H(6A) 108.7 
C(8)-C(7)-C(9) 110.26(12) 
C(8)-C(7)-C(6) 111.48(14) 
C(9)-C(7)-C(6) 108.97(12) 
C(8)-C(7)-H(7A) 108.7 
C(9)-C(7)-H(7A) 108.7 
C(6)-C(7)-H(7A) 108.7 
C(7)-C(8)-H(8A) 109.5 
C(7)-C(8)-H(8B) 109.5 
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H(8A)-C(8)-H(8B) 109.5 
C(7)-C(8)-H(8C) 109.5 
H(8A)-C(8)-H(8C) 109.5 
H(8B)-C(8)-H(8C) 109.5 
C(7)-C(9)-H(9A) 109.5 
C(7)-C(9)-H(9B) 109.5 
H(9A)-C(9)-H(9B) 109.5 
C(7)-C(9)-H(9C) 109.5 
H(9A)-C(9)-H(9C) 109.5 
H(9B)-C(9)-H(9C) 109.5 
C(5)-C(6A)-C(10) 110.7(5) 
C(5)-C(6A)-C(7A) 106.9(5) 
C(10)-C(6A)-C(7A) 103.7(5) 
C(5)-C(6A)-H(6AA) 111.7 
C(10)-C(6A)-H(6AA) 111.7 
C(7A)-C(6A)-H(6AA) 111.7 
C(8A)-C(7A)-C(9A) 111.3(5) 
C(8A)-C(7A)-C(6A) 111.0(5) 
C(9A)-C(7A)-C(6A) 108.9(5) 
C(8A)-C(7A)-H(7AA) 108.5 
C(9A)-C(7A)-H(7AA) 108.5 
C(6A)-C(7A)-H(7AA) 108.5 
C(7A)-C(8A)-H(8AA) 109.5 
C(7A)-C(8A)-H(8AB) 109.5 
H(8AA)-C(8A)-H(8AB) 109.5 
C(7A)-C(8A)-H(8AC) 109.5 
H(8AA)-C(8A)-H(8AC) 109.5 
H(8AB)-C(8A)-H(8AC) 109.5 
C(7A)-C(9A)-H(9AA) 109.5 
C(7A)-C(9A)-H(9AB) 109.5 
H(9AA)-C(9A)-H(9AB) 109.5 
C(7A)-C(9A)-H(9AC) 109.5 
H(9AA)-C(9A)-H(9AC) 109.5 
H(9AB)-C(9A)-H(9AC) 109.5 
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C(11)-C(10)-C(6) 174.04(13) 
C(11)-C(10)-C(6A) 160.7(3) 
C(6)-C(10)-C(6A) 24.8(3) 
C(10)-C(11)-C(12) 178.22(12) 
C(17)-C(12)-C(13) 119.16(12) 
C(17)-C(12)-C(11) 120.60(12) 
C(13)-C(12)-C(11) 120.21(12) 
C(14)-C(13)-C(12) 120.11(13) 
C(14)-C(13)-H(13A) 119.9 
C(12)-C(13)-H(13A) 119.9 
C(15)-C(14)-C(13) 120.05(13) 
C(15)-C(14)-H(14A) 120.0 
C(13)-C(14)-H(14A) 120.0 
C(14)-C(15)-C(16) 120.32(13) 
C(14)-C(15)-H(15A) 119.8 
C(16)-C(15)-H(15A) 119.8 
C(15)-C(16)-C(17) 120.30(14) 
C(15)-C(16)-H(16A) 119.8 
C(17)-C(16)-H(16A) 119.8 
C(16)-C(17)-C(12) 120.06(13) 
C(16)-C(17)-H(17A) 120.0 
C(12)-C(17)-H(17A) 120.0 
C(5)-N(1)-C(4) 126.66(12) 
C(5)-N(1)-C(1) 120.93(13) 
C(4)-N(1)-C(1) 112.39(9) 
C(3)-O(1)-C(2) 110.46(9) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters  (Å2x 103) for compound 65k.  The anisotropic 
displacement factor exponent takes the form:  -2π 2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
C(1) 34(1)  33(1) 23(1)  4(1) -3(1)  -12(1) 
C(2) 34(1)  29(1) 29(1)  3(1) -7(1)  -6(1) 
C(3) 34(1)  36(1) 36(1)  3(1) -1(1)  -13(1) 
C(4) 31(1)  25(1) 28(1)  4(1) 0(1)  -4(1) 
C(5) 28(1)  26(1) 27(1)  0(1) -6(1)  2(1) 
C(6) 22(1)  21(1) 24(1)  1(1) -4(1)  -3(1) 
C(7) 24(1)  22(1) 29(1)  -2(1) -4(1)  0(1) 
C(8) 40(1)  34(1) 27(1)  -5(1) -4(1)  1(1) 
C(9) 26(1)  30(1) 38(1)  -3(1) -3(1)  5(1) 
C(6A) 22(1)  21(1) 24(1)  1(1) -4(1)  -3(1) 
C(7A) 24(1)  22(1) 29(1)  -2(1) -4(1)  0(1) 
C(8A) 40(1)  34(1) 27(1)  -5(1) -4(1)  1(1) 
C(9A) 26(1)  30(1) 38(1)  -3(1) -3(1)  5(1) 
C(10) 33(1)  25(1) 23(1)  0(1) -4(1)  2(1) 
C(11) 28(1)  24(1) 24(1)  1(1) -2(1)  -3(1) 
C(12) 24(1)  21(1) 26(1)  4(1) 0(1)  -3(1) 
C(13) 34(1)  24(1) 26(1)  2(1) -2(1)  -4(1) 
C(14) 40(1)  21(1) 39(1)  1(1) 8(1)  -1(1) 
C(15) 28(1)  30(1) 65(1)  8(1) -6(1)  6(1) 
C(16) 41(1)  35(1) 61(1)  7(1) -26(1)  -3(1) 
C(17) 37(1)  24(1) 36(1)  1(1) -11(1)  -4(1) 
N(1) 30(1)  28(1) 23(1)  4(1) -4(1)  -7(1) 
O(1) 38(1)  34(1) 32(1)  1(1) -8(1)  -13(1) 
O(2) 51(1)  32(1) 36(1)  -1(1) -10(1)  -11(1) 
______________________________________________________________________________ 
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for compound 65k. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
 H(1A) 5769 7432 -356 35 
H(1B) 4437 8952 -93 35 
H(2A) 285 8560 -181 37 
H(2B) 1995 8097 -1149 37 
H(3A) 735 5386 698 41 
H(3B) -477 6922 935 41 
H(4A) 3165 6187 1786 35 
H(4B) 4954 5674 838 35 
H(6A) 2307 7610 2722 27 
H(7A) 4455 9797 3204 31 
H(8A) 2956 9570 4795 53 
H(8B) 5118 8274 4458 53 
H(8C) 2116 8240 4544 53 
H(9A) 34 10829 3659 50 
H(9B) -815 9518 3367 50 
H(9C) 380 10376 2582 50 
H(6AA) 5489 9100 2865 27 
H(7AA) 1325 7692 3007 31 
H(8AA) 395 8523 4566 53 
H(8AB) 2771 9233 4427 53 
H(8AC) 3305 7649 4420 53 
H(9AA) -1639 9802 3213 50 
H(9AB) -53 9699 2200 50 
H(9AC) 713 10521 3024 50 
H(13A) 9617 3889 2027 34 
H(14A) 13187 2129 2212 42 
H(15A) 15795 2179 3425 52 
H(16A) 14872 3979 4460 54 
H(17A) 11342 5756 4283 39 
________________________________________________________________________________ 
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